WO2004083263A1 - Polymerisation and oligomerisation catalysts - Google Patents

Polymerisation and oligomerisation catalysts Download PDF

Info

Publication number
WO2004083263A1
WO2004083263A1 PCT/GB2004/001184 GB2004001184W WO2004083263A1 WO 2004083263 A1 WO2004083263 A1 WO 2004083263A1 GB 2004001184 W GB2004001184 W GB 2004001184W WO 2004083263 A1 WO2004083263 A1 WO 2004083263A1
Authority
WO
WIPO (PCT)
Prior art keywords
groups
formula
group
polymerisation
catalyst
Prior art date
Application number
PCT/GB2004/001184
Other languages
French (fr)
Inventor
Vernon Charles Gibson
Atanas Tomov
Original Assignee
Innovene Europe Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovene Europe Limited filed Critical Innovene Europe Limited
Priority to JP2006505990A priority Critical patent/JP5401011B2/en
Priority to BRPI0408549A priority patent/BRPI0408549B1/en
Priority to EP04721578.5A priority patent/EP1603957B1/en
Priority to KR1020057017626A priority patent/KR101273309B1/en
Priority to US10/549,314 priority patent/US7229943B2/en
Priority to AU2004222079A priority patent/AU2004222079B2/en
Priority to CA2519854A priority patent/CA2519854C/en
Priority to MXPA05009958A priority patent/MXPA05009958A/en
Publication of WO2004083263A1 publication Critical patent/WO2004083263A1/en
Priority to ZA2005/06886A priority patent/ZA200506886B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F4/00Polymerisation catalysts
    • C08F4/02Carriers therefor
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F136/00Homopolymers of compounds having one or more unsaturated aliphatic radicals, at least one having two or more carbon-to-carbon double bonds
    • C08F136/02Homopolymers of compounds having one or more unsaturated aliphatic radicals, at least one having two or more carbon-to-carbon double bonds the radical having only two carbon-to-carbon double bonds
    • C08F136/04Homopolymers of compounds having one or more unsaturated aliphatic radicals, at least one having two or more carbon-to-carbon double bonds the radical having only two carbon-to-carbon double bonds conjugated
    • C08F136/06Butadiene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F10/00Homopolymers and copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F10/00Homopolymers and copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
    • C08F10/02Ethene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F4/00Polymerisation catalysts
    • C08F4/42Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors
    • C08F4/44Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths or actinides
    • C08F4/60Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths or actinides together with refractory metals, iron group metals, platinum group metals, manganese, rhenium technetium or compounds thereof
    • C08F4/62Refractory metals or compounds thereof
    • C08F4/64Titanium, zirconium, hafnium or compounds thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F4/00Polymerisation catalysts
    • C08F4/42Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors
    • C08F4/44Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths or actinides
    • C08F4/60Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths or actinides together with refractory metals, iron group metals, platinum group metals, manganese, rhenium technetium or compounds thereof
    • C08F4/70Iron group metals, platinum group metals or compounds thereof
    • C08F4/7001Iron group metals, platinum group metals or compounds thereof the metallic compound containing a multidentate ligand, i.e. a ligand capable of donating two or more pairs of electrons to form a coordinate or ionic bond
    • C08F4/7003Bidentate ligand
    • C08F4/7004Neutral ligand
    • C08F4/7006NN
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F110/00Homopolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
    • C08F110/02Ethene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F210/00Copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
    • C08F210/02Ethene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F210/00Copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
    • C08F210/16Copolymers of ethene with alpha-alkenes, e.g. EP rubbers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F4/00Polymerisation catalysts
    • C08F4/42Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors
    • C08F4/44Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths or actinides
    • C08F4/60Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths or actinides together with refractory metals, iron group metals, platinum group metals, manganese, rhenium technetium or compounds thereof
    • C08F4/62Refractory metals or compounds thereof
    • C08F4/639Component covered by group C08F4/62 containing a transition metal-carbon bond
    • C08F4/63912Component covered by group C08F4/62 containing a transition metal-carbon bond in combination with an organoaluminium compound

Definitions

  • the present invention relates to transition metal-based polymerisation and oligomerisation catalysts and to their use in the polymerisation, copolymerisation and oligomerisation of olefins.
  • Commodity polyethylenes are commercially produced in a variety of different types and grades. Homopolymerisation of ethylene with transition metal based catalysts leads to the production of so-called "high density" grades of polyethylene. These polymers have relatively high stiffness and are useful for making articles where inherent rigidity is required. Copolymerisation of ethylene with higher 1 -olefins (eg butene, hexene or octene) is employed commercially to provide a wide variety of copolymers differing in density and in other important physical properties. Particularly important copolymers made by copolymerising ethylene with higher 1 -olefins using transition metal based catalysts are the copolymers having a density in the range of 0.91 to 0.93.
  • 1 -olefins eg butene, hexene or octene
  • linear low density polyethylene are in many respects similar to the so-called “low density” polyethylene produced by the high pressure free radical catalysed polymerisation of ethylene.
  • Such polymers and copolymers are used extensively in the manufacture of flexible blown film.
  • Polypropylenes are also commercially produced in a variety of different types and grades. Homopolymerisation of propylene with transition metal based catalysts leads to the production of grades with a wide variety of applications. Copolymers of propylene with ethylene or terpolymers with ethylene and higher 1 -olefins are also useful materials, often used in film applications.
  • metallocene catalysts for example biscyclopentadienylzirconiumdichloride-activated with alumoxane
  • metallocene catalysts for example biscyclopentadienylzirconiumdichloride-activated with alumoxane
  • Other derivatives of metallocenes have been ' shown to be potentially useful for producing polypropylene with good activity, molecular weight and tacticity control.
  • metallocene catalysts of this type suffer from a number of disadvantages, for example, high sensitivity to impurities when used with commercially available monomers, diluents and process gas streams, the need to use large quantities of expensive alumoxanes to achieve high activity, difficulties in putting the catalyst on to a suitable support and synthetic difficulties in the production of more complex catalyst structures suitable for polymerising propene in a tactic manner.
  • Olefm oligomerisation is also a commercially important process, leading to the production of 1 -olefins (1-hexene, 1-octene, 1-decene, etc) that find utility in a wide range of applications, for example as comonomers for linear low densitypolyethylene, monomers for poly(l -olefins) and starting materials for surfactants.
  • Catalysts based on a wide range of metal complexes may be used for this process and typically produce a so-called "Schulz-Flory" distribution of 1 -olefins. More recently catalysts have emerged that selectively produce only 1 -hexene by a distinctive trimerisation mechanism.
  • An object of the present invention is to provide a catalyst suitable for polymerising or oligomerising monomers, for example, olefins, cycloolefins or diolefms, and especially for polymerising or oligomerising ethylene alone or propylene alone, or for copolymerising ethylene with higher 1 -olefins with high activity.
  • a further object of the invention is to provide an improved process for the polymerisation of olefins.
  • Yet another object of the present invention is to provide novel complexes based on certain transition metals.
  • the catalysts described here show extremely high activity for polymerisation and oligomerisation which leads to many benefits including lower catalyst loadings in a commercial process and lower catalyst residues in the final product.
  • the present invention provides a novel polymerisation catalyst comprising .
  • Z comprises a five-membered heterocyclic group, the five membered heterocyclic group containing at least one carbon atom, at least one nitrogen atom and at least one other hetero atom selected from nitrogen, sulphur and oxygen, the remaining atoms in said ring being selected from nitrogen and carbon;
  • M is a metal from Group 3 to 11 of the Periodic Table or a lanthanide metal;
  • E 1 and E 2 are divalent groups independently selected from (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups and (vi) heterosubstituted derivatives of said groups (i) to (v);
  • D 1 and D 2 are donor atoms or groups;
  • X is an anionic group, L is a neutral donor group;
  • y and z are independently zero or integers such that the number of X and L groups satisfy the
  • At least one of the atoms present in the ring of the five-membered heterocyclic group Z is preferably bonded directly to E 1 and preferably a second atom in the ring is bonded directly to M. Most preferably the atom in the five-membered ring bonded directly to E 1 is adjacent to a second atom in said ring, said second atom being bonded directly to M.
  • the five-membered heterocyclic group Z preferably contains at least 2 carbon atoi ⁇ s in its ring and more preferably at least 3 carbon atoms in its ring.
  • suitable 5-membered heterocyclic groups are (but are not restricted to):
  • Z, in Formula A is specifically an imidazole-containing group
  • the present invention further provides a novel polymerisation catalyst comprising
  • a fransition metal compound having the following Formula A, and optionally
  • Z is specifically an imidazole-containing group
  • M is a metal from Group 3 to 11 of the Periodic Table or a lanthanide metal
  • E 1 and E 2 are divalent groups independently selected from (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups and (vi) heterosubstituted derivatives of said groups (i) to (v);
  • D 1 and D 2 are donor groups;
  • X is an anionic group, L is a neutral donor group;
  • y and z are independently zero or integers such that the number of X and L groups satisfy the valency and oxidation state of the metal M.
  • D 1 and / or D 2 are donor atoms or " groups containing at least one donor atom.
  • D 1 and / or D 2 can be, for example, groups having the same formula as recited for group Z.
  • D and / or D can be groups comprising a five-membered heterocyclic group containing at least 2 carbon atoms in its ring and more preferably at least 3 carbon atoms in its ring.
  • D 1 and / or D 2 can be imidazole-containing groups if desired. When D 1 and / or D 2 are an imidazole-containing group this or these can be identical with Z. In a prefened embodiment D 2 and Z are identical imidazole containing groups.
  • the imidazole-containing group Z is preferably a group of formula I, II or in
  • R 1 to R 11 are independently hydrogen or a monovalent (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups, (vi) heterosubstituted derivatives of said groups (i) to (v), and (vii) hydrocarbyl-substituted heteroatom groups.
  • the "free" valence bond on the left of Formulae I, II and HI provides at least one of the links of E into the rest of Formula A.
  • the other link or links are preferably provided by at least one of the nitrogen atoms in the imidazole-containing group.
  • R 1 to R 11 preferably contain 1 to 30, more preferably 2 to 20, most preferably 2 to 12 carbon atoms.
  • suitable aliphatic hydrocarbon groups are methyl, ethyl, ethyleny], butyl, hexyl, isopropyl and tert-butyl.
  • suitable alicyclic hydrocarbon groups are adamantyl, norbornyl, cyclopentyl and cyclohexyl.
  • suitable aromatic hydrocarbon groups are phenyl, biphenyl, naphthyl, phenanthryl and anthryl.
  • alkyl substituted aromatic hydrocarbon groups examples include benzyl, tolyl, mesityl, 2,6-diisopropylphenyl and 2,4,6-triisopropyl.
  • suitable heterocyclic groups are 2-pyridinyl, 3-pyridinyl, 2-thiophenyl, 2-furanyl, 2-pyrrolyl, 2-quinolinyl.
  • Suitable substituents for forming heterosubstituted derivatives of said groups R 1 to R n are, for example, chloro, bromo, fluoro, iodo, nitro, amino, cyano, ether, hydroxyl and silyl, methoxy, ethoxy, phenoxy (i.e.
  • -OC 6 H 5 tolyloxy (i.e. -OC 6 H (CH 3 )), xylyloxy, mesityloxy, dimethylamino, diethylamino, methylethylamino, thiomethyl, thiophenyl and trimethylsilyl.
  • suitable heterosubstituted derivatives of said groups (i) to (v) are 2-chloroethyl, 2-bromocyclohexyl, 2-nitrophenyl, 4-ethoxyphenyl, 4-chloro-2- pyridinyl, 4-dimethylaminophenyl and 4-methylaminophenyl.
  • hydrocarbyl-substituted heteroatom groups are chloro, bromo, fluoro, iodo, nitro, amino, cyano, ether, hydroxyl and silyl, methoxy, ethoxy, phenoxy (i.e. -OC 6 H 5 ), tolyloxy (i.e. -OC 6 H (CH 3 )), xylyloxy, mesityloxy, dimethylamino, diethylamino, methylethylamino, thiomethyl, thiophenyl and trimethylsilyl.
  • Any of the substituents R 1 to R 11 may be linked to form cyclic structures.
  • Substituents R to R may also suitably be inorganic groups such as fluoro, chloro, bromo, iodo, nitro, amino, cyano and hydroxyl.
  • imidazole-containing groups may be obtained by removal of substituent Ri, for example by deprotonation when R 1 is hydrogen, to give formally monoanionic imidazole-containing groups.
  • the imidazole-containing group has a structure described in formula m (a "benzimidazole”).
  • R 1 is preferably hydrogen, an aliphatic hydrocarbon group, an aromatic hydrocarbon group or is removed to give a formally monoanionic
  • R to R are preferably hydrogen, an aliphatic hydrocarbon group or an aromatic hydrocarbon group.
  • E 1 and E 2 can be the same or different.
  • E is independently selected from divalent (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups, (vi) heterosubstituted derivatives of said groups (i) to (v), and (vii) hydrocarbyl-substituted heteroatom groups.
  • divalent groups E are -CH 2 -, -CH 2 CH 2 -, -CH 2 CH 2 CH 2 -, 1,2-phenylene, trans- 1,2-cyclopentane, trans-1,2- cyclohexane, 2,3-butane, 1,1 '-biphenyl, l,l '-binaphthyl, and -Si(Me) 2 -.
  • E is an aliphatic or aromatic hydrocarbon group. More preferably the divalent group E is -CH 2 -.
  • D 1 and D 2 can be the same or different donor groups, for example oxygen, sulfur, an amine, an imine or a phosphine.
  • D 1 and D 2 are selected from oxygen, sulfur, an amine of formula -N(R 12 )- or a phosphine of formula -P(R 13 )- wherein R 12 and R 13 are hydrogen or (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups, (vi) heterosubstituted derivatives of said groups (i) to (v), (vii) hydrocarbyl-substituted heteroatom groups and (viii) further imidazole-containing groups.
  • R 12 or R 13 may be removed, for example by deprotonation when they are hydrogen, to give a formally monoanionic fragment; or if both R 12 or R 13 are removed they provide a formally dianionic fragment.
  • D 2 is an amine of formula -N(R 12 )- as defined above.
  • R 12 is preferably hydrogen, an aliphatic hydrocarbon, an aromatic hydrocarbon or a further imidazole containing group.
  • D 2 is an imidazole-containing group.
  • M is preferably a metal selected from Groups 3 to 11 of the periodic table, preferably from Groups 3 to 7, more preferably selected from Sc, Ti, Zr, Hfi V, Nb, Ta, Cr, Mo, W, Mn and most preferably V, Cr, Ti, Zr and Hf
  • the anionic group X can be, for example, a halide, preferably chloride or bromide; or a hydrocarbyl group, for example, methyl, benzyl or phenyl; a carboxylate, for example, acetate or an acetylacetonate; an oxide; an amide, for example diethyl amide; an alkoxide, for example, methoxide, ethoxide or phenoxide; or a hydroxyl.
  • X can be a non-coordinating or weakly-coordinating anion, for example, tefrafluoroborate, a fluorinated aryl borate or a triflate.
  • the anionic groups X may be the same or different and may independently be monoanionic, dianionic or trianionic.
  • the neutral donor group L can be, for example, a solvate molecule, for example diethyl ether or THF; an amine, for example, diethyl amine, trimethylamine or pyridine; a phosphine, for example trimethyl phosphine or triphenyl phosphine; or water; or an olefm or a tortral, conjugated or nonconjugated diene, optionally substituted with one or more groups selected from hydrocarbyl or trimethylsilyl groups, said group having up to 40 carbon atoms and forming a pi-complex with M.
  • a solvate molecule for example diethyl ether or THF
  • an amine for example, diethyl amine, trimethylamine or pyridine
  • a phosphine for example trimethyl phosphine or triphenyl phosphine
  • water or an olefm or a damral, conjugated or nonconjugated diene, optionally
  • L is a diene ligand
  • it can be, for example s-trans- ⁇ 4 -l,4-diphenyl-l,3-butadiene; s-trans- ⁇ 4 -3-methyl-l,3- pentadiene; s-trans- ⁇ 4 -l,4-dibenzyl-l,3-butadiene; s-trans- ⁇ 4 -2,4-hexadiene; s-trans- ⁇ 4 - 1 ,3-pentadiene; s-trans- ⁇ 4 - 1 ,4-ditolyl- 1 ,3-butadiene; s-frans- ⁇ 4 - 1 ,4-bis(trimethylsilyl)- 1,3-butadiene; s-trans- ⁇ 4 -l,4-diphenyl-l,3-butadiene; s-cis- ⁇ 4 -3 -methyl- 1,3-pentadiene; s-cis- ⁇ 4
  • the optional activator (2) for the catalyst of the present invention is suitably selected from organoaluminium compounds and organoboron compounds or mixtures thereof.
  • organoaluminium compounds include trialkyaluminium compounds, for example, trimethylaluminium, triethylaluminium, tributylaluminium, toi-n-octylaluminium, ethylaluminium dichloride, diethylaluminium chloride, tris(pentafluorophenyl)aluminium and alumoxanes.
  • Alumoxanes are well known in the art as typically the oligomeric compounds which can be prepared by the controlled addition of water to an alkylaluminium compound, for example trimethylaluminium.
  • organoboron compounds are dimethylphenylammoniumtefra(phenyl)borate, frityltefra(phenyl)borate, triphenylboron, dimethylphenylammonium tetra(pentafluorophenyl)borate, sodium tetrakis[(bis-3,5-frifluoromethyl)phenyl]borate, H + (OEt 2 )[(bis-3,5- trifiuoromethyl)phenyl]borate, trityltetra(pentafluorophenyl)borate and tris(pentafluorophenyl) boron.
  • organoaluminium compounds and organoboron compounds may be used.
  • the quantity of activating compound selected from organoaluminium compounds and organoboron compounds to be employed is easily determined by simple testing, for example, by the preparation of small test samples which can be used to polymerise small quantities of the monomer(s) and thus to determine the activity of the produced catalyst. It is generally found that the quantity employed is sufficient to provide 0.1 to 20,000 atoms, preferably 1 to 2000 atoms of aluminium or boron per atom of M present in the compound of Formula A. Mixtures t»f different activating compounds may be used.
  • EP1238989 discloses the use of activators (Lewis acids) selected from (b-1) ionic-bonding compounds having a CdCl 2 type or a Cdl 2 type of layered crystal structure;
  • the activator employed in the present invention may be of the type disclosed in EP1238989 if desired.
  • Such Lewis acids are those compounds which capable of receiving at least one electron pair and is capable of forming an ion pair by reaction with the transition metal complex.
  • the Lewis acid includes the afore-mentioned (b-1) ionic- bonding compounds having a layered crystal structure of a CdCl 2 type or Cdl 2 type (b-2) clay . clay minerals, or ion-exchange layered compounds, (b-3) heteropoly compounds, and (b-4) halogenated lanthanoid compounds.
  • the Lewis acid further includes SiO 2 , Al 2 O 3 , natural and synthetic zeolites which have Lewis acid points formed by heating or a like treatment, and complexes and mixtures thereof.
  • US Patent 6399535 discloses a coordinating catalyst system capable of polymerizing olefins comprising: (I) as a pre-catalyst, at least one non-metallocene, non-constrained geometry, bidentate ligand containing transition metal compound or fridentate ligand containing transition metal compound capable of (A) being activated upon contact with the catalyst support- activator agglomerate of (II) or (B) being converted, upon contact with an organometallic compound, to an intermediate capable of being activated upon contact with the catalyst support-activator agglomerate of (II), wherein the transition metal is at least one member selected from Groups 3 to 10 of the Periodic table; in intimate contact with
  • catalyst support-activator agglomerate comprising a composite of (A) at least one inorganic oxide component selected from SiO 2 , Al 2 O 3 , MgO, AlPO 4 , TiO 2 , ZrO 2 , and
  • halogenated organic compounds that can be used in this manner are ethyl, trichloroacetate, chloroform (CHC1 3 ) and n-butylchloride.
  • US Patent.5191042 also . refers to the disclosure of Cooper (T. A Cooper, Journ. Am. Chem. Soc, 4158 (1973), which defines in Table 1 an organic halide activity index based on the ability of the halide to oxidize certain vanadium compounds under standard conditions.
  • carbon tetrachloride is assigned a reactivity of 1 in tetrahydrofuran at 20 °C.
  • other listed halogenated organic compounds have reactivities of from about 0.02 to greater than 200 relative to carbon tetrachloride.
  • a halogenated promotor it is prefened to use those having a Cooper Index ranging from about 0.01 up to about 30.
  • the use of such promoters, especially in combination with vanadium-based catalysts is generally well known in the art, and for details of use of the such promoters reference may be made to US Patent.5191042 and to other prior art in this field.
  • imidazole nucleus shown within the dotted circle is selected from the divalent groups represented by the Formulae la, Ha, Ula, IVa, Va and Via,
  • M is a metal from Group 3 to 11 of the Periodic Table or a lanthanide metal
  • E l and E 2 are divalent groups independently selected from (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups and_(vi) heterosubstituted derivatives of said
  • D 1 and D 2 can be the same or different donor groups, for example oxygen, sulfur, an amine, an imine or a
  • D and D are selected from oxygen, sulfur, an amine of formula
  • R and R are hydrogen or (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups, (vi) heterosubstituted derivatives of said groups (i) to (v), (vii) hydrocarbyl-substituted heteroatom groups and (viii) further imidazole-containing groups.
  • -OC 6 H 5 ), tolyloxy (i.e. -OC 6 H 4 (CH 3 )), xylyloxy, mesityloxy, dimethylamino, diethylamino, methylethylamino, thiomethyl, thiophenyl and frimethylsilyl.
  • suitable heterosubstituted derivatives of said groups (i) to (v) are 2-chl ⁇ roethyl, 2- bromocyclohexyl, 2-nifrophenyl, 4-ethoxyphenyl, 4-chloro-2-pyridinyl, 4- dimethylaminophenyl and 4-methylaminophenyl.
  • hydrocarbyl- substituted heteroatom groups examples include chloro, bromo, fluoro, iodo, nitro, amino, cyano, ether, hydroxyl and silyl, methoxy, ethoxy, phenoxy (i.e. -OC 6 H 5 ), tolyloxy (i.e. -
  • DI, El, Z, M, X, L, y and z are as defined above, and wherein the imidazole nucleus within the dotted circle is selected from the divalent groups represented by the Formulae la, Ila, Hla, IVa, Va and Via
  • ligands represent some examples of those suitable for making the complexes of Formula C and D in accordance with the present invention.
  • ligands can be used to make complexes and catalysts in accordance with the present invention wherein the transition metal is preferably titanium, zirconium, hafnium, vanadium or chromium.
  • transition metal complexes that can be employed in the catalyst of the present invention: -
  • R1-R 3 alkyl, aryl, etc.
  • R1 - R4 alkyl, aryl, etc.
  • Z divalent organic or Inorganic radical as -CH2-, -0-,
  • Z divalent organic or inorganic radical as -CH2-, -0-, etc.
  • X CI, Br, I, NMe2, OR, SR, etc.
  • the catalyst of the present invention can, if desired, be utilised on a support material.
  • Suitable support materials are, for example, silica, alumina, or zirconia, magnesia, magnesium chloride or a polymer or prepolymer, for example polyethylene, polystyrene, or poly(aminostyrene).
  • the catalysts of the present invention can if desired comprise more than one of the defined fransition metal compounds.
  • the catalysts of the present invention can also include one or more other catalysts for polymerising 1 -olefins.
  • catalysts are other types of transition metal compounds or catalysts, for example, transition metal compounds of the type used in conventional
  • the catalysts can be formed in situ in the presence of the support material, or the support material can be pre-impregnated or premixed, simultaneously or sequentially, with one or more of the catalyst components.
  • the catalysts of the present invention can if desired be supported on a heterogeneous catalyst, for example, a magnesium halide supported Ziegler Natta catalyst, a Phillips type (chromium oxide) supported catalyst or a supported metallocene catalyst. Formation of the supported catalyst can be achieved for example by treating the fransition metal compounds of the present invention with alumoxane in a suitable inert diluent, for example a volatile hydrocarbon, slurrying a particulate support material with the product and evaporating the volatile diluent.
  • the produced supported catalyst is preferably in the form of a free- flowing powder.
  • the quantity of support material employed can vary widely, for example from 100,000 to 1 grams per gram of metal present in the transition metal compound.
  • the present invention further provides a process for the polymerisation and copolymerisation of 1 -olefins, cycloolefins or dienes, comprising contacting the monomer under polymerisation conditions with the polymerisation catalyst of the present invention.
  • Suitable monomers for use in making homopolymers using the polymerisation process of the present invention are, for example, ethylene, propylene, butene, hexene, styrene or conjugated or non-conjugated dienes.
  • Prefened monomers are ethylene and propylene.
  • Suitable monomers for use in making copolymers using the polymerisation process of the present invention are ethylene, propylene, 1-butene, 1-hexene, 4- methylpentene-1, 1-octene, norbornene, substituted norbornenes, dienes, eg butadiene, ethylidene norbornene, methyl methacrylate, methyl acrylate, butyl acrylate, acrylonitrile, vinyl acetate, vinyl chloride, and styrene.
  • a particularly prefened process in accordance with the present invention is the copolymerisation of ethylene and or propylene with comonomers selected from 1- olefms, acrylic acid esters, vinyl esters and vinyl aromatic compounds.
  • suitable comonomers are 1-butene, 1-hexene, 4-methylpentene-l, methyl methacrylate, methyl acrylate, butyl acrylate, acrylonitrile, vinyl acetate, and styrene.
  • Prefened polymerisation processes are the homopolymerisation of ethylene or the homopolymerisation of propylene or copolymerisation of ethylene with one or more of propylene, butene, hexene- 1 and 4-methylpentene-l or copolymerisation of propylene with one or more of ethylene or butene.
  • the polymerisation conditions can be, for example, bulk phase, solution phase, slurry phase or gas phase.
  • the catalyst can be used to polymerise ethylene under high pressure/high temperature process conditions wherein the polymeric material forms as a melt in supercritical ethylene.
  • the polymerisation is conducted under gas phase fluidised or strrred bed conditions.
  • Slurry phase polymerisation conditions or gas phase polymerisation conditions are particulariy useful for the production of high-density grades of polyethylene.
  • the polymerisation conditions can be batch, continuous or semi- continuous.
  • the catalyst is generally fed to the polymerisation zone in the form of a particulate solid.
  • This solid can be, for example, an undiluted solid catalyst system formed from the complex A and an activator, or can be the solid complex A alone. In the latter situation, the activator can be fed to the polymerisation zone, for example as a solution, separately from or together with the solid complex.
  • the catalyst system or the transition metal complex component of the catalyst system employed in the slurry polymerisation and gas phase polymerisation is supported on a support material.
  • the catalyst system is supported on a support material prior to its introduction into the polymerisation zone.
  • Suitable support materials are, for example, silica, alumina, zirconia, talc, kieselguhr, magnesia, magnesium chloride and polymers. Impregnation of the support material can be canied out by conventional techniques, for example, by forming a solution or suspension of the catalyst components in a suitable diluent or solvent, and slurrying the support material therewith. The support material thus impregnated with catalyst can then be separated from the diluent for example, by filtration or evaporation techniques.
  • the solid particles of catalyst, or supported catalyst are fed to a polymerisation zone either as dry powder or as a slurry in the polymerisation diluent.
  • a polymerisation zone is fed to a polymerisation zone as a suspension in the polymerisation diluent.
  • the polymerisation zone can be, for example, an autoclave or similar reaction vessel, or a continuous loop reactor, e.g. of the type well know in the manufacture of polyethylene by the Phillips Process.
  • the polymerisation process of the present invention is carried out under slurry conditions the polymerisation is preferably carried out at a temperature above 0°C, most preferably above 15°C.
  • the polymerisation temperature is preferably maintained below the temperature at which the polymer commences to soften or sinter in the presence of the polymerisation diluent. If the temperature is allowed to go above the latter temperature, fouling of the reactor can occur. Adjustment of the polymerisation within these defined temperature ranges can provide a useful means of controlling the average molecular weight of the producedpolymer.
  • a further useful means of controlling the molecular weight is to conduct the polymerisation in the presence of hydrogen gas which acts as chain fransfer agent. Generally, the higher the concentration of hydrogen employed, the lower the average molecular weight of the produced polymer.
  • the use of hydrogen gas as a means of controlling the average molecular weight of the polymer or copolymer applies generally to the polymerisation process of the present invention.
  • hydrogen can be used to reduce the average molecular weight of polymers or copolymers prepared using gas phase, slurry phase or solution phase polymerisation conditions.
  • the quantity of hydrogen gas to be employed to give the desired average molecular weight can be determined by simple "trial and error" polymerisation tests.
  • Methods for operating gas phase polymerisation processes are well known in the art. Such methods generally involve agitating (e.g. by stirring, vibrating or fiuidising) a bed of catalyst, or a bed of the target polymer (i.e.
  • the catalyst, or one or more of the components employed to form the catalyst can, for example, be introduced into the polymerisation reaction zone in liquid form, for example, as a solution in an inert liquid diluent.
  • the transition metal component, or the activator component, or both of these components can be dissolved or slurried in a liquid diluent and fed to the polymerisation zone. Under these circumstances it is prefened the liquid containing the component(s) is sprayed as fine droplets into the polymerisation zone.
  • the droplet diameter is preferably within the range 1 to 1000 microns.
  • EP-A-0593083 discloses a process for introducing a polymerisation catalyst into a gas phase polymerisation.
  • the methods disclosed in EP-A-0593083 can be suitably employed in the polymerisation process of the present invention if desired.
  • the present invention also provides a process for the oligomerisation and cooligomerisation of 1 -olefins, comprising contacting the monomeric olefm under oligomerisation conditions with the catalyst of the present invention.
  • the oligomerisation and co-oligomerisation reactions of the present invention can be performed under a range of process conditions that are readily apparent to those skilled in the art: as a homogeneous liquid phase reaction in the presence or absence of an inert hydrocarbon diluent such as toluene or heptanes; as a two-phase liquid/liquid reaction; as a slurry process where the catalyst is in a form that displays little or no solubility; as a bulk process in which essentially neat reactant and/or product olefins serve as the dominant medium; as a gas-phase process in which at least a portion of the reactant or product olefin(s) are transported to or from a supported form of the catalyst via the gaseous state.
  • Evaporative cooling from one or more monomers or inert volatile liquids is but one method that can be employed to effect the removal of heat from the reaction.
  • the (co-)oligomerisation reactions may be performed in the known types of gas-phase reactors, such as circulating bed, vertically or horizontally stirred-bed, fixed-bed, or fluidised-bed reactors, liquid-phase reactors, such as plug-flow, continuously stined tank, or loop reactors, or combinations thereof.
  • gas-phase reactors such as circulating bed, vertically or horizontally stirred-bed, fixed-bed, or fluidised-bed reactors
  • liquid-phase reactors such as plug-flow, continuously stined tank, or loop reactors, or combinations thereof.
  • a wide range of methods for effecting product, reactant, and catalyst separation and/or purification are known to those skilled in the art and may be employed: distillation, filtration, liquid-liquid separation, slurry settling, extraction, etc.
  • One or more of these methods may be performed separately from the (co-)oligomerisation reaction or it may be advantageous to integrate at least some with 'a (co-)oligomerisation reaction; a non- limiting example of this would be a process employing catalytic (or reactive) distillation. Also advantageous may be a process which includes more than one reactor, a catalyst kill system between reactors or after the final reactor, or an integrated reactor/separator/purifier. While all catalyst components, reactants, inerts, and products could be employed in the present invention on a once-through basis, it is often economically advantageous to recycle one or more of these materials; in the case of the catalyst system, this might require reconstituting one or more of the catalysts components to achieve the active catalyst system.
  • the catalyst systems of the present invention can present a variety of advantages over the prior art systems.
  • the catalysts are easy to synthesise, have high activity and good catalyst life when employed under conventional industrial . polymerisation conditions.
  • the catalysts exhibit single site behaviour which tends to favour the production of narrow molecular weight distribution polymers having uniform properties.
  • the vanadium based catalysts of the present invention are capable of making very high molecular weight polymers.
  • a further aspect of the present invention provides a novel fransition metal compound having the Formula A
  • M is preferably selected from Groups 3 to 7 of the periodic table.
  • a prefened novel transition metal compound in accordance with the present has the Formula
  • Z is specifically an imidazole-containing group of formula:
  • R R 8 , R 9 , R 10 and R ⁇ are independently hydrogen or a monovalent (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups, (vi) heterosubstituted derivatives of said groups (i) to (v), and (vii) hydrocarbyl-substituted heteroatom groups.
  • These defined groups preferably contain 1 to 30, more preferably 2 to 20, most preferably 2 to 12 carbon atoms.
  • suitable aliphatic hydrocarbon groups are methyl, ethyl, ethylenyl, butyl, hexyl, isopropyl and tert-butyl.
  • heterosubstituted derivatives of said groups (i) to (v) are 2-chloroethyl, 2- bromocyclohexyl, 2-nitro ⁇ henyl, 4-ethoxyphenyl, 4-chloro-2-pyridinyl, 4- dimethyl aminophenyl and 4-methylaminophenyl.
  • suitable hydrocarbyl- substituted heteroatom groups are chloro, bromo, fluoro, iodo, nitro, amino, cyano, ether, hydroxyl and silyl, methoxy, ethoxy, phenoxy (i.e. -OC 6 H 5 ), tolyloxy (i.e.
  • substituents Ri to ⁇ maybe linked to form cyclic structures.
  • Substituents R 2 to R ⁇ may also suitably be inorganic groups such as fluoro, chloro, bromo, iodo, nitro, amino, cyano and hydroxyl.
  • Ri is preferably hydrogen, an aliphatic hydrocarbon group, an aromatic hydrocarbon group or is removed to give a formally monoanionic benzimidazole group.
  • R 8 to R ⁇ are preferably hydrogen, an aliphatic hydrocarbon group or an aromatic hydrocarbon group.
  • M is preferably a metal selected from Groups 3 to 11 of the periodic table, more preferably selected from Sc, Ti, Zr, Hf, V, Nb, Ta, Cr, Mo, W, Mn and most preferably V and Cr.
  • E is independently selected from divalent (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups, (vi) heterosubstituted derivatives of said groups (i) to (v), and (vii) hydrocarbyl-substituted heteroatom groups.
  • Examples of suitable divalent group R are -CH 2 -, -CH CH 2 -, -CH 2 CH 2 CH 2 -, 1,2-phenylene, tra72S-l,2-cyclopentane, trans-1,2- cyclohexane, 2,3-butane, 1 , 1 '-biphenyl, 1 , 1 '-binaphthyl, and -Si(Me) 2 -.
  • E is an aliphatic or aromatic hydrocarbon group. More preferably E is -CH -.
  • R 12 or R 13 may be removed, for example by deprotonation when they are hydrogen, to give a formally monoanionic fragments.
  • D is an amine of formula -N(R 1 )- as define above.
  • R 12 is preferably hydrogen, an aliphatic hydrocarbon, an aromatic hydrocarbon or a further imidazole containing group.
  • X is an anionic group and can be, for example, a halide, preferably chloride or bromide; or a hydrocarbyl group, for example, methyl, benzyl or phenyl; a carboxylate, for example, acetate or acetylacetate; an oxide; an amide, for example diethyl amide; an alkoxide, for example, methoxide, ethoxide or phenoxide.
  • X can be a non-coordinating or weakly-coordinating anion, for example, tefrafluoroborate, a fluorinated aryl borate or a triflate.
  • the anionic groups X may be the same or different and may independently be monoanionic, dianionic or trianionic.
  • L is a tortral donor group and can be, for example, a solvate molecule, for example diethyl ether or THF; an amine, for example, diethyl amine, frimethylamine or pyridine; a phosphine, for example trimethyl phosphine or triphenyl phosphine; or an olefm, or a neutral, conjugated or nonconjugated diene, optionally substituted with one or more groups selected from hydrocarbyl or trimethylsilyl groups, said L having up to 40 carbon atoms and forming a .pi.-complex with M.
  • Temperature set-point is the temperature at the start of the polymerisation reaction.
  • the temperature in the reactor is uncontrolled and will change from this point due to the heat formation during the polymerisation reaction.
  • ⁇ T is the difference between the temperature in the reactor and the temperature in the cooling bath
  • the activity is based on the sum of the soluble and insoluble fractions.
  • Example 11 In presence of 10 ml 1-hexene.
  • PMAO polymethylalumoxane
  • MMAO modified methylalumoxane
  • Example 23 In presence of ethylene (1 bar) and propylene (2 bar). GC curves for the soluble fractions in Example 21 are shown in Figure 10; for Example 22 in Figure 11 and for Example 23 in Figure 12.
  • Example 24 In presence of ethylene (1 bar) and propylene (2 bar). GC curves for the soluble fractions in Example 21 are shown in Figure 10; for Example 22 in Figure 11 and for Example 23 in Figure 12.
  • the ethylene polymerisation reactions were carried out either in a 400 ml "Fischer- • 20 Porter” glass reactor (FPR) equipped with a gas inlet, a catalyst inlet, a mechanical stiner and a digital thermometer or in a IL stainless-steel reactor (SSR) equipped with an integral system for control of reaction temperature, ethylene pressure and ethylene flow.
  • FPR "Fischer- • 20 Porter” glass reactor
  • SSR IL stainless-steel reactor
  • An aliquot of 1-5 ml of the catalyst solution described above was injected in the reactor containing 200 - 300 (FPR) or 400- 800 (SSR) ml solvent (usually toluene, n-
  • the reactor content was then poured into a beaker containing 400 ml methanol and a few drops of 2M HCL The polymer was filtered, washed with methanol (if necessary) and dried at 60°C under vacuum.
  • Me 2 AlCl dimethylaluminium chloride - DMAC
  • Runs 53 - 61 the amount of Me2AlCl shown includes the amount of the scavenger (0.5 mmol)
  • Example 74 activated catalyst solution aged for 27 hours.
  • Me 2 AlCl dimethylaluminium chloride - DMAC; the amount of Me 2 AlCl shown includes the amount of the scavenger (0.5 mmol)
  • Figures 16 and 17, respectively, show ethylene uptake as a function of time for Examples 77 and 78.
  • Examples 78-81 show ethylene uptake as a function of time for Examples 77 and 78.
  • Example 48 - 61 The ethylene copolymerisation tests were canied out using a procedure similar to that described in Example 48 - 61.
  • the required amounts of comonomer were preloaded in the polymerisation reactor.
  • Table V-2C-FP Polymerisation in toluene. Fisher-Porter glass reactor.
  • Example 48 - 61 The ethylene copolymerisation tests were canied out using a procedure similar to that described in Example 48 - 61.
  • the required amounts of comonomers were preloaded in the polymerisation reactor.
  • Table V-3HC-FP Polymerisation in toluene. Fisher-Porter glass reactor.
  • Table V-4HCT-FP Polymerisation in toluene. Fisher-Porter glass reactor.
  • Table V-6H-FP Polymerisation in toluene. Fisher-Porter glass reactor.
  • the ethylene polymerisation tests were carried out using a procedure similar to that described in Example 48 - 61.
  • the solid catalyst was preactivated and fransferred in the reactor ia cannula . .
  • Table V-2-SiO2H-FP Polymerisation in toluene. Fisher-Porter glass reactor.
  • TIBAL rriisobutyl aluminium
  • the ethylene polymerisation test was carried out using a procedure similar to that described in Example 48 - 61. 5 Table V-C1H-FP. Polymerisation in toluene. Fisher-Porter glass reactor.
  • Table V-C2H-FP Polymerisation in toluene. Fisher-Porter glass reactor.
  • Table V-C1H-FP Polymerisation in toluene. Fisher-Porter glass reactor.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A polymerisation catalyst comprising (1) a transition metal compound of Formula A, and optionally (2) an activating quantity of a Lewis acid activator, Formula (A), wherein Z is a five-membered heterocyclic group containing at least one carbon atom, at least one nitrogen atom and at least one other hetero atom selected from nitrogen, sulphur and oxygen, the remaining atoms in the ring being nitrogen or carbon; M is a metal from Group 3 to 11 of the Periodic Table or a lanthanide metal; E1 and E2 are divalent groups from (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups and (vi) heterosubstituted derivatives of groups (i) to (v); D' and D2 are donor groups; X is an anionic group, L is a neutral donor group; n = m = zero or 1; y and z are zero or integers. The catalysts are useful for polymerising or oligomerising 1-olefins.

Description

POLYMERISATION AND OLIGOMERISATION CATALYSTS
The present invention relates to transition metal-based polymerisation and oligomerisation catalysts and to their use in the polymerisation, copolymerisation and oligomerisation of olefins.
The use of certain transition metal compounds to polymerise 1 -olefins, for example, ethylene or propylene, is well established in the prior art. The use of Ziegler- Natta catalysts, for example, those catalysts produced by activating titanium halides with organometallic compounds such as triethylaluminium, is fundamental to many commercial processes for manufacturing polyolefins. Over the last three decades, advances in the technology have led to the development of Ziegler-Natta catalysts which have such high activities that olefm polymers and copolymers containing very low concentrations of residual catalyst can be produced directly in commercial polymerisation processes. The quantities of residual catalyst remaining in the produced polymer are so small as to render unnecessary their separation and removal for most commercial applications. Such processes can be operated by polymerising the monomers in the gas phase, or in solution or in suspension in a liquid hydrocarbon diluent, or, in the case of propylene in bulk.
Commodity polyethylenes are commercially produced in a variety of different types and grades. Homopolymerisation of ethylene with transition metal based catalysts leads to the production of so-called "high density" grades of polyethylene. These polymers have relatively high stiffness and are useful for making articles where inherent rigidity is required. Copolymerisation of ethylene with higher 1 -olefins (eg butene, hexene or octene) is employed commercially to provide a wide variety of copolymers differing in density and in other important physical properties. Particularly important copolymers made by copolymerising ethylene with higher 1 -olefins using transition metal based catalysts are the copolymers having a density in the range of 0.91 to 0.93. These copolymers which are generally referred to in the art as "linear low density polyethylene" are in many respects similar to the so-called "low density" polyethylene produced by the high pressure free radical catalysed polymerisation of ethylene. Such polymers and copolymers are used extensively in the manufacture of flexible blown film.
Polypropylenes are also commercially produced in a variety of different types and grades. Homopolymerisation of propylene with transition metal based catalysts leads to the production of grades with a wide variety of applications. Copolymers of propylene with ethylene or terpolymers with ethylene and higher 1 -olefins are also useful materials, often used in film applications.
In recent years the use of certain metallocene catalysts (for example biscyclopentadienylzirconiumdichloride-activated with alumoxane) has provided catalysts with potentially high activity. Other derivatives of metallocenes have been ' shown to be potentially useful for producing polypropylene with good activity, molecular weight and tacticity control. However, metallocene catalysts of this type suffer from a number of disadvantages, for example, high sensitivity to impurities when used with commercially available monomers, diluents and process gas streams, the need to use large quantities of expensive alumoxanes to achieve high activity, difficulties in putting the catalyst on to a suitable support and synthetic difficulties in the production of more complex catalyst structures suitable for polymerising propene in a tactic manner. Olefm oligomerisation is also a commercially important process, leading to the production of 1 -olefins (1-hexene, 1-octene, 1-decene, etc) that find utility in a wide range of applications, for example as comonomers for linear low densitypolyethylene, monomers for poly(l -olefins) and starting materials for surfactants. Catalysts based on a wide range of metal complexes may be used for this process and typically produce a so-called "Schulz-Flory" distribution of 1 -olefins. More recently catalysts have emerged that selectively produce only 1 -hexene by a distinctive trimerisation mechanism. Typically the final distribution of 1 -olefins produced is of importance commercially. An object of the present invention is to provide a catalyst suitable for polymerising or oligomerising monomers, for example, olefins, cycloolefins or diolefms, and especially for polymerising or oligomerising ethylene alone or propylene alone, or for copolymerising ethylene with higher 1 -olefins with high activity. A further object of the invention is to provide an improved process for the polymerisation of olefins. Yet another object of the present invention is to provide novel complexes based on certain transition metals. The catalysts described here show extremely high activity for polymerisation and oligomerisation which leads to many benefits including lower catalyst loadings in a commercial process and lower catalyst residues in the final product.
The present invention provides a novel polymerisation catalyst comprising .
(1) a transition metal compound having the following Formula A, and optionally
(2) an activating quantity of a suitable activator,
Formula A
Figure imgf000005_0001
wherein Z comprises a five-membered heterocyclic group, the five membered heterocyclic group containing at least one carbon atom, at least one nitrogen atom and at least one other hetero atom selected from nitrogen, sulphur and oxygen, the remaining atoms in said ring being selected from nitrogen and carbon; M is a metal from Group 3 to 11 of the Periodic Table or a lanthanide metal; E1 and E2 are divalent groups independently selected from (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups and (vi) heterosubstituted derivatives of said groups (i) to (v); D1 and D2 are donor atoms or groups; X is an anionic group, L is a neutral donor group; n = m = zero or 1; y and z are independently zero or integers such that the number of X and L groups satisfy the valency and oxidation state of the metal M. Preferably the divalent groups E and E are not linked other than tlirough the donor atom or group D1.
At least one of the atoms present in the ring of the five-membered heterocyclic group Z is preferably bonded directly to E1 and preferably a second atom in the ring is bonded directly to M. Most preferably the atom in the five-membered ring bonded directly to E1 is adjacent to a second atom in said ring, said second atom being bonded directly to M.
The five-membered heterocyclic group Z preferably contains at least 2 carbon atoiηs in its ring and more preferably at least 3 carbon atoms in its ring. Examples of suitable 5-membered heterocyclic groups are (but are not restricted to):
Figure imgf000006_0001
Figure imgf000006_0002
Figure imgf000006_0003
Figure imgf000006_0004
Figure imgf000006_0005
Figure imgf000007_0001
Figure imgf000007_0002
Figure imgf000007_0003
Figure imgf000007_0004
hi a prefened embodiment of the present invention Z, in Formula A, is specifically an imidazole-containing group
Thus, the present invention further provides a novel polymerisation catalyst comprising
(1) a fransition metal compound having the following Formula A, and optionally
(2) an activating quantity of a suitable activator, Formula A
Figure imgf000008_0001
wherein Z is specifically an imidazole-containing group; M is a metal from Group 3 to 11 of the Periodic Table or a lanthanide metal; E1 and E2 are divalent groups independently selected from (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups and (vi) heterosubstituted derivatives of said groups (i) to (v); D1 and D2 are donor groups; X is an anionic group, L is a neutral donor group; n = m = zero or 1; y and z are independently zero or integers such that the number of X and L groups satisfy the valency and oxidation state of the metal M.
D1 and / or D2 are donor atoms or"groups containing at least one donor atom. D1 and / or D2 can be, for example, groups having the same formula as recited for group Z.
1
For example D and / or D can be groups comprising a five-membered heterocyclic group containing at least 2 carbon atoms in its ring and more preferably at least 3 carbon atoms in its ring. D1 and / or D2 can be imidazole-containing groups if desired. When D1 and / or D2 are an imidazole-containing group this or these can be identical with Z. In a prefened embodiment D2 and Z are identical imidazole containing groups.
The imidazole-containing group Z is preferably a group of formula I, II or in
Figure imgf000008_0002
R1 to R11 are independently hydrogen or a monovalent (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups, (vi) heterosubstituted derivatives of said groups (i) to (v), and (vii) hydrocarbyl-substituted heteroatom groups. The "free" valence bond on the left of Formulae I, II and HI provides at least one of the links of E into the rest of Formula A. The other link or links are preferably provided by at least one of the nitrogen atoms in the imidazole-containing group. These defined groups R1 to R11 preferably contain 1 to 30, more preferably 2 to 20, most preferably 2 to 12 carbon atoms. Examples of suitable aliphatic hydrocarbon groups are methyl, ethyl, ethyleny], butyl, hexyl, isopropyl and tert-butyl. Examples of suitable alicyclic hydrocarbon groups are adamantyl, norbornyl, cyclopentyl and cyclohexyl. Examples of suitable aromatic hydrocarbon groups are phenyl, biphenyl, naphthyl, phenanthryl and anthryl. Examples of suitable alkyl substituted aromatic hydrocarbon groups are benzyl, tolyl, mesityl, 2,6-diisopropylphenyl and 2,4,6-triisopropyl. Examples of suitable heterocyclic groups are 2-pyridinyl, 3-pyridinyl, 2-thiophenyl, 2-furanyl, 2-pyrrolyl, 2-quinolinyl. Suitable substituents for forming heterosubstituted derivatives of said groups R1 to Rn are, for example, chloro, bromo, fluoro, iodo, nitro, amino, cyano, ether, hydroxyl and silyl, methoxy, ethoxy, phenoxy (i.e. -OC6H5), tolyloxy (i.e. -OC6H (CH3)), xylyloxy, mesityloxy, dimethylamino, diethylamino, methylethylamino, thiomethyl, thiophenyl and trimethylsilyl. Examples of suitable heterosubstituted derivatives of said groups (i) to (v) are 2-chloroethyl, 2-bromocyclohexyl, 2-nitrophenyl, 4-ethoxyphenyl, 4-chloro-2- pyridinyl, 4-dimethylaminophenyl and 4-methylaminophenyl. Examples of suitable hydrocarbyl-substituted heteroatom groups are chloro, bromo, fluoro, iodo, nitro, amino, cyano, ether, hydroxyl and silyl, methoxy, ethoxy, phenoxy (i.e. -OC6H5), tolyloxy (i.e. -OC6H (CH3)), xylyloxy, mesityloxy, dimethylamino, diethylamino, methylethylamino, thiomethyl, thiophenyl and trimethylsilyl. Any of the substituents R1 to R11 may be linked to form cyclic structures. Substituents R to R may also suitably be inorganic groups such as fluoro, chloro, bromo, iodo, nitro, amino, cyano and hydroxyl.
Further suitable imidazole-containing groups may be obtained by removal of substituent Ri, for example by deprotonation when R1 is hydrogen, to give formally monoanionic imidazole-containing groups.
It is preferred that the imidazole-containing group has a structure described in formula m (a "benzimidazole"). R1 is preferably hydrogen, an aliphatic hydrocarbon group, an aromatic hydrocarbon group or is removed to give a formally monoanionic
' 8 1 1 benzimidazole group. R to R are preferably hydrogen, an aliphatic hydrocarbon group or an aromatic hydrocarbon group.
E1 and E2 (hereinafter referced to as "E") can be the same or different. E is independently selected from divalent (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups, (vi) heterosubstituted derivatives of said groups (i) to (v), and (vii) hydrocarbyl-substituted heteroatom groups. Examples of suitable divalent groups E are -CH2-, -CH2CH2-, -CH2 CH2CH2-, 1,2-phenylene, trans- 1,2-cyclopentane, trans-1,2- cyclohexane, 2,3-butane, 1,1 '-biphenyl, l,l '-binaphthyl, and -Si(Me)2-. It is preferred that E is an aliphatic or aromatic hydrocarbon group. More preferably the divalent group E is -CH2-.
D1 and D2 can be the same or different donor groups, for example oxygen, sulfur, an amine, an imine or a phosphine. Preferably D1 and D2 are selected from oxygen, sulfur, an amine of formula -N(R12)- or a phosphine of formula -P(R13)- wherein R12 and R13 are hydrogen or (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups, (vi) heterosubstituted derivatives of said groups (i) to (v), (vii) hydrocarbyl-substituted heteroatom groups and (viii) further imidazole-containing groups. Alternatively R12 or R13 may be removed, for example by deprotonation when they are hydrogen, to give a formally monoanionic fragment; or if both R12 or R13 are removed they provide a formally dianionic fragment. More preferably D2 is an amine of formula -N(R12)- as defined above. R12 is preferably hydrogen, an aliphatic hydrocarbon, an aromatic hydrocarbon or a further imidazole containing group. Preferably D2 is an imidazole-containing group.
M is preferably a metal selected from Groups 3 to 11 of the periodic table, preferably from Groups 3 to 7, more preferably selected from Sc, Ti, Zr, Hfi V, Nb, Ta, Cr, Mo, W, Mn and most preferably V, Cr, Ti, Zr and Hf The anionic group X can be, for example, a halide, preferably chloride or bromide; or a hydrocarbyl group, for example, methyl, benzyl or phenyl; a carboxylate, for example, acetate or an acetylacetonate; an oxide; an amide, for example diethyl amide; an alkoxide, for example, methoxide, ethoxide or phenoxide; or a hydroxyl. Alternatively, X can be a non-coordinating or weakly-coordinating anion, for example, tefrafluoroborate, a fluorinated aryl borate or a triflate. The anionic groups X may be the same or different and may independently be monoanionic, dianionic or trianionic. The neutral donor group L can be, for example, a solvate molecule, for example diethyl ether or THF; an amine, for example, diethyl amine, trimethylamine or pyridine; a phosphine, for example trimethyl phosphine or triphenyl phosphine; or water; or an olefm or a neufral, conjugated or nonconjugated diene, optionally substituted with one or more groups selected from hydrocarbyl or trimethylsilyl groups, said group having up to 40 carbon atoms and forming a pi-complex with M. When L is a diene ligand, it can be, for example s-trans-η4-l,4-diphenyl-l,3-butadiene; s-trans-η4-3-methyl-l,3- pentadiene; s-trans-η4-l,4-dibenzyl-l,3-butadiene; s-trans-η4-2,4-hexadiene; s-trans-η4- 1 ,3-pentadiene; s-trans-η4- 1 ,4-ditolyl- 1 ,3-butadiene; s-frans-η4- 1 ,4-bis(trimethylsilyl)- 1,3-butadiene; s-trans-η4-l,4-diphenyl-l,3-butadiene; s-cis-η4-3 -methyl- 1,3-pentadiene; s-cis-η4- 1,4-dibenzyl- 1,3 -butadiene; s-cis-η4-2,4-hexadiene; s-cis-η4- 1,3-pentadiene; s- cis-η4-l,4-ditolyl-l,3-butadiene; or s-cis-η4- l,4-bis(trimethylsilyl)-l,3-butadiene, said s- cis isomers forming a .pi. -bound diene complex;
The value of y depends on the formal charge on each group Z and D, the charge on the anionic group X and the oxidation state of the metal M. For example, if M is chromium in oxidation state +3, Z is a neutral group and both D groups are neutral, then y is 3 if X is a monoanionic group (eg. chloride); if M is chromium in oxidation state +3, the Z group is neutral, one D group is monoanionic and the other D is neutral, then y is 2 if all X groups are monoanionic groups (e.g. chloride).
The optional activator (2) for the catalyst of the present invention is suitably selected from organoaluminium compounds and organoboron compounds or mixtures thereof. Examples of organoaluminium compounds include trialkyaluminium compounds, for example, trimethylaluminium, triethylaluminium, tributylaluminium, toi-n-octylaluminium, ethylaluminium dichloride, diethylaluminium chloride, tris(pentafluorophenyl)aluminium and alumoxanes. Alumoxanes are well known in the art as typically the oligomeric compounds which can be prepared by the controlled addition of water to an alkylaluminium compound, for example trimethylaluminium. Such compounds can be linear, cyclic or mixtures thereof. Commercially available alumoxanes are generally believed to be mixtures of linear, cyclic and cage compounds. The cyclic alumoxanes can be represented by the formula [R16AlO]s and the linear alumoxanes by the formula R17(R18AlO)s wherein s is a number from about 2 to 50, and wherein R16, R17, and R18 represent hydrocarbyl groups, preferably C\ to C6 alkyl groups, for example methyl, ethyl or butyl groups. Examples of suitable organoboron compounds are dimethylphenylammoniumtefra(phenyl)borate, frityltefra(phenyl)borate, triphenylboron, dimethylphenylammonium tetra(pentafluorophenyl)borate, sodium tetrakis[(bis-3,5-frifluoromethyl)phenyl]borate, H+(OEt2)[(bis-3,5- trifiuoromethyl)phenyl]borate, trityltetra(pentafluorophenyl)borate and tris(pentafluorophenyl) boron. Mixtures of organoaluminium compounds and organoboron compounds may be used. hi the preparation of the catalysts of the present invention the quantity of activating compound selected from organoaluminium compounds and organoboron compounds to be employed is easily determined by simple testing, for example, by the preparation of small test samples which can be used to polymerise small quantities of the monomer(s) and thus to determine the activity of the produced catalyst. It is generally found that the quantity employed is sufficient to provide 0.1 to 20,000 atoms, preferably 1 to 2000 atoms of aluminium or boron per atom of M present in the compound of Formula A. Mixtures t»f different activating compounds may be used. EP1238989 discloses the use of activators (Lewis acids) selected from (b-1) ionic-bonding compounds having a CdCl2 type or a Cdl2 type of layered crystal structure;
(b-2) clays, clay minerals, or ion-exchange layered compounds; (b-3) heteropoly-compounds; and
(b-4) halogenated lanthanoid compounds. The activator employed in the present invention may be of the type disclosed in EP1238989 if desired. Such Lewis acids are those compounds which capable of receiving at least one electron pair and is capable of forming an ion pair by reaction with the transition metal complex. The Lewis acid includes the afore-mentioned (b-1) ionic- bonding compounds having a layered crystal structure of a CdCl2 type or Cdl2 type (b-2) clay . clay minerals, or ion-exchange layered compounds, (b-3) heteropoly compounds, and (b-4) halogenated lanthanoid compounds. The Lewis acid further includes SiO2, Al2O3, natural and synthetic zeolites which have Lewis acid points formed by heating or a like treatment, and complexes and mixtures thereof.
US Patent 6399535 discloses a coordinating catalyst system capable of polymerizing olefins comprising: (I) as a pre-catalyst, at least one non-metallocene, non-constrained geometry, bidentate ligand containing transition metal compound or fridentate ligand containing transition metal compound capable of (A) being activated upon contact with the catalyst support- activator agglomerate of (II) or (B) being converted, upon contact with an organometallic compound, to an intermediate capable of being activated upon contact with the catalyst support-activator agglomerate of (II), wherein the transition metal is at least one member selected from Groups 3 to 10 of the Periodic table; in intimate contact with
(II) catalyst support-activator agglomerate comprising a composite of (A) at least one inorganic oxide component selected from SiO2, Al2O3, MgO, AlPO4, TiO2, ZrO2, and
Cr2O3 and (B) at least one ion containing layered material having interspaces between the layers and sufficient Lewis acidity, when present within the catalyst support- activator agglomerate, to activate the pre-catalyst when the pre-catalyst is in contact with the catalyst support-activator agglomerate, said layered material having a cationic component and an anionic component, wherein said cationic component is present within the interspaces of the layered material, said layered material being intimately associated with said inorganic oxide component within the agglomerate in an amount sufficient to improve the activity of the coordinating catalyst system for polymerizing ethylene monomer, expressed as Kg of polyethylene per gram of catalyst system per hour, relative to the activity of a corresponding catalyst system employing the same pre- catalyst but in the absence of either Component A or B of the catalyst support- activator agglomerate; wherein the amounts of the pre-catalyst and catalyst support-activator agglomerate which are in intimate contact are sufficient to provide a ratio of micromoles of pre-catalyst to grams of catalyst support-activator agglomerate of from about 5:1 to about 500: 1. The layered material can be, for example, a smectite clay. The catalyst system of the present invention can be employed with a catalyst support-activator agglomerate as described in US 6399535 if desired.
In addition to the activator compound, it can be advantageous to employ catalytic quantities of certain halogenated compounds that are capable of promoting catalyst activity. Promotors of this type are especially useful in the case that the transition metal in the complex is vanadium. US Patent.5191042 discloses that certain vanadium-based catalysts activated with organoaluminium compounds can be promoted using a variety of halogenated organic compounds, for example, carbon tetrachloride, hexachloroethylene, benzylbromide, benzylchloride and 2,3- or 1,3-dichloropropylene. Other examples of halogenated organic compounds that can be used in this manner are ethyl, trichloroacetate, chloroform (CHC13) and n-butylchloride. US Patent.5191042 also . refers to the disclosure of Cooper (T. A Cooper, Journ. Am. Chem. Soc, 4158 (1973), which defines in Table 1 an organic halide activity index based on the ability of the halide to oxidize certain vanadium compounds under standard conditions. For example, carbon tetrachloride is assigned a reactivity of 1 in tetrahydrofuran at 20 °C., and other listed halogenated organic compounds have reactivities of from about 0.02 to greater than 200 relative to carbon tetrachloride. When it is desired, to use a halogenated promotor, it is prefened to use those having a Cooper Index ranging from about 0.01 up to about 30. The use of such promoters, especially in combination with vanadium-based catalysts is generally well known in the art, and for details of use of the such promoters reference may be made to US Patent.5191042 and to other prior art in this field. In the present invention it is possible to employ any halogenated organic compound as a promoter, but the compounds mentioned above are prefened.
A preferred embodiment of the present invention provides a catalyst comprising
(1) a transition metal compound having the following Formula B or C, and optionally
(2) an activating quantity of a suitable activator,
Formula C
Formula B
Figure imgf000014_0001
Figure imgf000014_0002
wherein the imidazole nucleus shown within the dotted circle is selected from the divalent groups represented by the Formulae la, Ha, Ula, IVa, Va and Via,
Figure imgf000015_0001
wherein M is a metal from Group 3 to 11 of the Periodic Table or a lanthanide metal; El and E2 are divalent groups independently selected from (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups and_(vi) heterosubstituted derivatives of said
1 9 groups (i) to (v); D and D are donor groups; X is an anionic group, L is a neutral donor group; n = m = zero or 1; y and.z are independently zero or integers such that the number of X and L groups satisfy the valency and oxidation state of the metal M, wherein the groups R2 to R11 are independently hydrogen or a monovalent (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups, (vi) heterosubstituted derivatives of said groups (i) to (v), and (vii) hydrocarbyl-substituted heteroatom groups. M is preferably selected from Groups 3 to 7 of the periodic table.
Groups R2 to R11 are preferably selected from the groups defined above in relation to the Formula I, II, HI, IV, V and VI groups.
In this prefened embodiment of the present invention, D1 and D2 can be the same or different donor groups, for example oxygen, sulfur, an amine, an imine or a
1 9 phosphine. Preferably D and D are selected from oxygen, sulfur, an amine of formula
11 1 ^ 19 1 ^
-N(R )- or a phosphine of formula -P(R )- wherein R and R are hydrogen or (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups, (vi) heterosubstituted derivatives of said groups (i) to (v), (vii) hydrocarbyl-substituted heteroatom groups and (viii) further imidazole-containing groups.
Preferably D1 is nitrogen for example -NR - or =N- or a nitrogen-containing group, for example -NCR^-R20- wherein R1 represents a monovalent group and R20 represents a divalent group derived from, for example, aliphatic hydrocarbon groups such as methyl, ethyl, ethylenyl, butyl, hexyl, isopropyl and tert-butyl. Examples of suitable alicyclic hydrocarbon groups are adamantyl, norbornyl, cyclopentyl and cyclohexyl. Examples of suitable aromatic hydrocarbon groups are phenyl, biphenyl, naphthyl, phenanthryl and anthryl. Examples of suitable alkyl substituted aromatic hydrocarbon groups are benzyl, tolyl, mesityl, 2,6-diisopropylphenyl and 2,4,6- triisopropyl. Examples of suitable heterocyclic groups are 2-pyridinyl, 3-pyridinyl, 2- thiophenyl, 2-furanyl, 2-pyrcolyl, 2-quinolinyl. Suitable substituents for forming heterosubstituted derivatives of said groups R1 to R11 are, for example, chloro, bromo, fluoro, iodo, nitro, amino, cyano, ether, hydroxyl and silyl, methoxy, ethoxy, phenoxy (i.e. -OC6H5), tolyloxy (i.e. -OC6H4(CH3)), xylyloxy, mesityloxy, dimethylamino, diethylamino, methylethylamino, thiomethyl, thiophenyl and frimethylsilyl. Examples of suitable heterosubstituted derivatives of said groups (i) to (v) are 2-chlόroethyl, 2- bromocyclohexyl, 2-nifrophenyl, 4-ethoxyphenyl, 4-chloro-2-pyridinyl, 4- dimethylaminophenyl and 4-methylaminophenyl. Examples of suitable hydrocarbyl- substituted heteroatom groups are chloro, bromo, fluoro, iodo, nitro, amino, cyano, ether, hydroxyl and silyl, methoxy, ethoxy, phenoxy (i.e. -OC6H5), tolyloxy (i.e. -
OC6H4(CH3)), xylyloxy, mesityloxy, dimethylamino, diethylamino, methylethylamino, thiomethyl, thiophenyl and trimethylsilyl. Any of the substituents R1 to Rn may be
9 1 1 linked to form cyclic structures. Substituents R to R may also suitably be inorganic groups such as fluoro, chloro, bromo, iodo, nitro, amino, cyano and hydroxyl Preferably D2 is a imidazole group selected from the groups of Formula la, Lla and ma above.
As indicated above, the values of m and n in the present invention are such that m = n = zero or one. For the avoidance of doubt, this means that for a given complex, when m is zero, n is also zero. And when m is 1, n is also 1. When m and n are zero in Formula A, the Formula reduces to Formula D, preferably to Formula E or Formula F
Figure imgf000017_0001
wherein DI, El, Z, M, X, L, y and z are as defined above, and wherein the imidazole nucleus within the dotted circle is selected from the divalent groups represented by the Formulae la, Ila, Hla, IVa, Va and Via
Figure imgf000017_0002
The following ligands represent some examples of those suitable for making the complexes of Formula C and D in accordance with the present invention.
Figure imgf000018_0001
Figure imgf000018_0002
Figure imgf000018_0003
Figure imgf000018_0004
Figure imgf000019_0001
Figure imgf000019_0002
Formula 30
Formula 31
Figure imgf000019_0003
Fom ula 33 Formula 33
Figure imgf000019_0004
Formula 34 Formula 35
Figure imgf000020_0001
Formula 36
Figure imgf000020_0002
Formula 39
Figure imgf000020_0003
Formula 40
Figure imgf000020_0004
Formula 43
Figure imgf000021_0001
Figure imgf000021_0002
Figure imgf000021_0003
Formula 48
Figure imgf000021_0004
Formula A9
Figure imgf000021_0005
Formula 50
Figure imgf000021_0006
Figure imgf000022_0001
Formula 52 Formula 53
Figure imgf000022_0002
Formula 54
Formula 55
Figure imgf000022_0003
Formula 56 Formula 57
Figure imgf000022_0004
Formula 58 Formula 59
Figure imgf000023_0001
Formula 61
Formula 60
Figure imgf000023_0002
Formula 62 Formula 63
Figure imgf000023_0003
Formula 64 Formula 65
Figure imgf000023_0004
Formula 66 Formula 67
Figure imgf000024_0001
Formula 68 Formula 69
Figure imgf000024_0002
Formula 70 Formula 71
Figure imgf000024_0003
Formula 72 Formula 73
Figure imgf000024_0004
Formula 74 Formula 75
Figure imgf000025_0001
Formula 76 Formula 77
Figure imgf000025_0002
Formula 78 Formula 79
Figure imgf000025_0003
Formula 80 Formula 81
Figure imgf000025_0004
Formula 82 Formula 83
Figure imgf000026_0001
Formula 84 Formula 85
Figure imgf000026_0002
Formula 86
Figure imgf000026_0003
Figure imgf000026_0004
Formula 88 Formula 89
Figure imgf000026_0005
Formula 90 Formula 91
Figure imgf000027_0001
Formula 92 Formula 93
Figure imgf000027_0002
Formula 94 Formula 95
Figure imgf000027_0003
Formula 96 Formula 97
Figure imgf000027_0004
Formula 98
Figure imgf000028_0001
Figure imgf000028_0002
Formula 102
Formula 103
Figure imgf000028_0003
Formula 104 Formula 105
Figure imgf000028_0004
Formula 106 Formula 107
Figure imgf000029_0001
Formula 109
Fonnula 108
Figure imgf000029_0002
Formula 110 Formula 111
Figure imgf000029_0003
Formula 112 Formula 113
Figure imgf000029_0004
Formula 114 Formula 115
Figure imgf000030_0001
Pormula 1 17
Formula 116
Figure imgf000030_0002
Formula 118 Formula 119
Figure imgf000030_0003
Formula 120
Figure imgf000030_0004
Formula 122 Formula 123
Figure imgf000031_0001
Formula 124 Formula 125
Figure imgf000031_0002
Formula 126 Formula 127
Figure imgf000031_0003
Formula 129
Formula 128
Figure imgf000031_0004
Formula 130 Formula 131
Figure imgf000032_0001
Formula 132 Formula 133
Figure imgf000032_0002
Formula 134 Formula 135
Figure imgf000032_0003
Formula 136 Formula 137
Figure imgf000032_0004
Formula 138 Formula 139
Figure imgf000033_0001
Formula 140 Formula 141
Figure imgf000033_0002
Formula 143
Formula 142
Figure imgf000033_0003
Formula 144 Formula 145
Figure imgf000033_0004
Formula 147
Foraiula 146
Figure imgf000034_0001
Formula 148 Formula 149
Figure imgf000034_0002
Formula 150 Formula 151
Figure imgf000034_0003
Formula 152 Formula 153
Figure imgf000034_0004
Formula 154
Formula 155
Figure imgf000035_0001
Formula 157
Formula 156
These ligands can be used to make complexes and catalysts in accordance with the present invention wherein the transition metal is preferably titanium, zirconium, hafnium, vanadium or chromium.
The following are examples of transition metal complexes that can be employed in the catalyst of the present invention: -
Figure imgf000036_0001
Figure imgf000036_0002
Figure imgf000037_0001
Figure imgf000037_0003
Figure imgf000037_0002
Figure imgf000037_0004
•25
0
Figure imgf000038_0001
Figure imgf000038_0002
Figure imgf000038_0004
Figure imgf000038_0003
Figure imgf000038_0005
Figure imgf000038_0006
R1-R3 = alkyl, aryl, etc.
Figure imgf000039_0001
Figure imgf000039_0002
Figure imgf000039_0003
Figure imgf000039_0004
The following Formulae illusfrate the fransition metal compounds according to the present invention wherein L is a diene:
Figure imgf000040_0001
R1 - R4 = alkyl, aryl, etc. Z = divalent organic or Inorganic radical as -CH2-, -0-,
Figure imgf000040_0002
Z = divalent organic or inorganic radical as -CH2-, -0-, etc.
X = CI, Br, I, NMe2, OR, SR, etc.
The catalyst of the present invention can, if desired, be utilised on a support material. Suitable support materials are, for example, silica, alumina, or zirconia, magnesia, magnesium chloride or a polymer or prepolymer, for example polyethylene, polystyrene, or poly(aminostyrene). The catalysts of the present invention can if desired comprise more than one of the defined fransition metal compounds.
In addition to said one or more defined transition metal compounds, the catalysts of the present invention can also include one or more other catalysts for polymerising 1 -olefins. Preferably such catalysts are other types of transition metal compounds or catalysts, for example, transition metal compounds of the type used in conventional
Ziegler-Natta catalyst systems, metallocene-based catalysts, or heat activated supported chromium oxide catalysts (eg Phillips-type catalyst). The catalysts of the present invention may also used in conjunction with other catalysts producing only 1 -olefins, either inside or outside the polymerisation reactor, and in this way make copolymers of ethylene or propylene and these 1 -olefins. Suitable catalysts for producing 1 -olefins may produce only 1-butene, only 1-hexene or a distribution (for example, a Schulz- Flory distribution) of 1 -olefins.
If desired the catalysts can be formed in situ in the presence of the support material, or the support material can be pre-impregnated or premixed, simultaneously or sequentially, with one or more of the catalyst components. The catalysts of the present invention can if desired be supported on a heterogeneous catalyst, for example, a magnesium halide supported Ziegler Natta catalyst, a Phillips type (chromium oxide) supported catalyst or a supported metallocene catalyst. Formation of the supported catalyst can be achieved for example by treating the fransition metal compounds of the present invention with alumoxane in a suitable inert diluent, for example a volatile hydrocarbon, slurrying a particulate support material with the product and evaporating the volatile diluent. The produced supported catalyst is preferably in the form of a free- flowing powder. The quantity of support material employed can vary widely, for example from 100,000 to 1 grams per gram of metal present in the transition metal compound.
The present invention further provides a process for the polymerisation and copolymerisation of 1 -olefins, cycloolefins or dienes, comprising contacting the monomer under polymerisation conditions with the polymerisation catalyst of the present invention.
Suitable monomers for use in making homopolymers using the polymerisation process of the present invention are, for example, ethylene, propylene, butene, hexene, styrene or conjugated or non-conjugated dienes. Prefened monomers are ethylene and propylene.
Suitable monomers for use in making copolymers using the polymerisation process of the present invention are ethylene, propylene, 1-butene, 1-hexene, 4- methylpentene-1, 1-octene, norbornene, substituted norbornenes, dienes, eg butadiene, ethylidene norbornene, methyl methacrylate, methyl acrylate, butyl acrylate, acrylonitrile, vinyl acetate, vinyl chloride, and styrene.
A particularly prefened process in accordance with the present invention is the copolymerisation of ethylene and or propylene with comonomers selected from 1- olefms, acrylic acid esters, vinyl esters and vinyl aromatic compounds. Examples of suitable comonomers are 1-butene, 1-hexene, 4-methylpentene-l, methyl methacrylate, methyl acrylate, butyl acrylate, acrylonitrile, vinyl acetate, and styrene.
Prefened polymerisation processes are the homopolymerisation of ethylene or the homopolymerisation of propylene or copolymerisation of ethylene with one or more of propylene, butene, hexene- 1 and 4-methylpentene-l or copolymerisation of propylene with one or more of ethylene or butene.
The polymerisation conditions can be, for example, bulk phase, solution phase, slurry phase or gas phase. If desired, the catalyst can be used to polymerise ethylene under high pressure/high temperature process conditions wherein the polymeric material forms as a melt in supercritical ethylene. Preferably the polymerisation is conducted under gas phase fluidised or strrred bed conditions.
Slurry phase polymerisation conditions or gas phase polymerisation conditions are particulariy useful for the production of high-density grades of polyethylene. In these processes the polymerisation conditions can be batch, continuous or semi- continuous. In the slurry phase process and the gas phase process, the catalyst is generally fed to the polymerisation zone in the form of a particulate solid. This solid can be, for example, an undiluted solid catalyst system formed from the complex A and an activator, or can be the solid complex A alone. In the latter situation, the activator can be fed to the polymerisation zone, for example as a solution, separately from or together with the solid complex. Preferably the catalyst system or the transition metal complex component of the catalyst system employed in the slurry polymerisation and gas phase polymerisation is supported on a support material. Most preferably the catalyst system is supported on a support material prior to its introduction into the polymerisation zone. Suitable support materials are, for example, silica, alumina, zirconia, talc, kieselguhr, magnesia, magnesium chloride and polymers. Impregnation of the support material can be canied out by conventional techniques, for example, by forming a solution or suspension of the catalyst components in a suitable diluent or solvent, and slurrying the support material therewith. The support material thus impregnated with catalyst can then be separated from the diluent for example, by filtration or evaporation techniques.
In the slurry phase polymerisation process the solid particles of catalyst, or supported catalyst, are fed to a polymerisation zone either as dry powder or as a slurry in the polymerisation diluent. Preferably the particles are fed to a polymerisation zone as a suspension in the polymerisation diluent. The polymerisation zone can be, for example, an autoclave or similar reaction vessel, or a continuous loop reactor, e.g. of the type well know in the manufacture of polyethylene by the Phillips Process. When the polymerisation process of the present invention is carried out under slurry conditions the polymerisation is preferably carried out at a temperature above 0°C, most preferably above 15°C. The polymerisation temperature is preferably maintained below the temperature at which the polymer commences to soften or sinter in the presence of the polymerisation diluent. If the temperature is allowed to go above the latter temperature, fouling of the reactor can occur. Adjustment of the polymerisation within these defined temperature ranges can provide a useful means of controlling the average molecular weight of the producedpolymer. A further useful means of controlling the molecular weight is to conduct the polymerisation in the presence of hydrogen gas which acts as chain fransfer agent. Generally, the higher the concentration of hydrogen employed, the lower the average molecular weight of the produced polymer. The use of hydrogen gas as a means of controlling the average molecular weight of the polymer or copolymer applies generally to the polymerisation process of the present invention. For example, hydrogen can be used to reduce the average molecular weight of polymers or copolymers prepared using gas phase, slurry phase or solution phase polymerisation conditions. The quantity of hydrogen gas to be employed to give the desired average molecular weight can be determined by simple "trial and error" polymerisation tests. Methods for operating gas phase polymerisation processes are well known in the art. Such methods generally involve agitating (e.g. by stirring, vibrating or fiuidising) a bed of catalyst, or a bed of the target polymer (i.e. polymer having the same or similar physical properties to that which it is desired to make in the polymerisation process) containing a catalyst, and feeding thereto a stream of monomer at least partially in the gaseous phase, under conditions such that at least part of the monomer polymerises in contact with the catalyst in the bed. The bed is generally cooled by the addition of cool gas (eg recycled gaseous monomer) and/or volatile liquid (eg a volatile inert hydrocarbon, or gaseous monomer which has been condensed to form a liquid). The polymer produced in, and isolated from, gas phase processes forms directly a solid in the polymerisation zone and is free from, or substantially free from liquid. As is well known to those skilled in the art, if any liquid is allowed to enter the polymerisation zone of a gas phase polymerisation process the quantity of liquid is small in relation to the quantity of polymer present in the polymerisation zone. This is in contrast to "solution phase" processes wherein the polymer is formed dissolved in a solvent, and "slurry phase" processes wherein the polymer forms as a suspension in a liquid diluent. The gas phase process can be operated under batch, semi-batch, or so-called "continuous" conditions. It is preferred to operate under conditions such that monomer is continuously recycled to an agitated polymerisation zone containing polymerisation catalyst, make-up monomer being provided to replace polymerised monomer, and continuously or intermittently withdrawing produced polymer from the polymerisation zone at a rate comparable to the rate of formation Of the polymer, fresh catalyst being added to the polymerisation zone to replace the catalyst withdrawn form the polymerisation zone with the produced polymer.
When using the catalysts of the present invention under gas phase polymerisation conditions, the catalyst, or one or more of the components employed to form the catalyst can, for example, be introduced into the polymerisation reaction zone in liquid form, for example, as a solution in an inert liquid diluent. Thus, for example, the transition metal component, or the activator component, or both of these components can be dissolved or slurried in a liquid diluent and fed to the polymerisation zone. Under these circumstances it is prefened the liquid containing the component(s) is sprayed as fine droplets into the polymerisation zone. The droplet diameter is preferably within the range 1 to 1000 microns. EP-A-0593083, the teaching of which is hereby incorporated into this specification, discloses a process for introducing a polymerisation catalyst into a gas phase polymerisation. The methods disclosed in EP-A-0593083 can be suitably employed in the polymerisation process of the present invention if desired. The present invention also provides a process for the oligomerisation and cooligomerisation of 1 -olefins, comprising contacting the monomeric olefm under oligomerisation conditions with the catalyst of the present invention.
Suitable monomers for use in making homooligomers using the oligomerisation process of the of the present invention are, for example, ethylene, propylene, butene, hexene, and styrene. The preferred monomer is ethylene. Suitable monomers for use in making co-oligomers using the oligomerisation process of the present invention are ethylene, propylene, 1-butene, 1-hexene, 1-octene, 1-decene, 1-dodecene and further 1 -olefins of the series C(n)H(2n) where n is an integer.
There exist a number of options for the oligomerisation reactor including batch, semi- batch, and continuous operation. The oligomerisation and co-oligomerisation reactions of the present invention can be performed under a range of process conditions that are readily apparent to those skilled in the art: as a homogeneous liquid phase reaction in the presence or absence of an inert hydrocarbon diluent such as toluene or heptanes; as a two-phase liquid/liquid reaction; as a slurry process where the catalyst is in a form that displays little or no solubility; as a bulk process in which essentially neat reactant and/or product olefins serve as the dominant medium; as a gas-phase process in which at least a portion of the reactant or product olefin(s) are transported to or from a supported form of the catalyst via the gaseous state. Evaporative cooling from one or more monomers or inert volatile liquids is but one method that can be employed to effect the removal of heat from the reaction. The (co-)oligomerisation reactions may be performed in the known types of gas-phase reactors, such as circulating bed, vertically or horizontally stirred-bed, fixed-bed, or fluidised-bed reactors, liquid-phase reactors, such as plug-flow, continuously stined tank, or loop reactors, or combinations thereof. A wide range of methods for effecting product, reactant, and catalyst separation and/or purification are known to those skilled in the art and may be employed: distillation, filtration, liquid-liquid separation, slurry settling, extraction, etc. One or more of these methods may be performed separately from the (co-)oligomerisation reaction or it may be advantageous to integrate at least some with 'a (co-)oligomerisation reaction; a non- limiting example of this would be a process employing catalytic (or reactive) distillation. Also advantageous may be a process which includes more than one reactor, a catalyst kill system between reactors or after the final reactor, or an integrated reactor/separator/purifier. While all catalyst components, reactants, inerts, and products could be employed in the present invention on a once-through basis, it is often economically advantageous to recycle one or more of these materials; in the case of the catalyst system, this might require reconstituting one or more of the catalysts components to achieve the active catalyst system. It is within the scope of this invention that a (co)oligomerisation product might-also serve as a reactant (e.g. 1 -hexene, produced via the oligomerisation of ethylene, might be converted to decene products via a subsequent co-oligomermerisation reaction with two further ethylene units).
The catalyst systems of the present invention can present a variety of advantages over the prior art systems. In general the catalysts are easy to synthesise, have high activity and good catalyst life when employed under conventional industrial . polymerisation conditions. Generally the catalysts exhibit single site behaviour which tends to favour the production of narrow molecular weight distribution polymers having uniform properties. Generally, the vanadium based catalysts of the present invention are capable of making very high molecular weight polymers. A further aspect of the present invention provides a novel fransition metal compound having the Formula A
Formula A
Figure imgf000046_0001
wherein Z comprises a five-membered heterocyclic group, the five membered heterocyclic group containing at least one carbon atom, at least one nitrogen atom and at least one other hetero atom selected from nitrogen, sulphur and oxygen, the remaining atoms in said ring being selected from nitrogen and carbon; M is a metal from Group 3 to 11 of the Periodic Table or a lanthanide metal; E1 and E2 are divalent groups independently selected from (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups and (vi) heterosubstituted derivatives of said groups (i) to (v); D1 and D2 are donor atoms or groups; X is an anionic group, L is a neufral donor group; n = m = zero or 1; y and z are independently zero or integers such that the number of X and L groups satisfy the valency and oxidation state of the metal M.
M is preferably selected from Groups 3 to 7 of the periodic table.
The preferences set out above in relation to the fransition metal complex component of the catalyst of the present invention apply equally to the novel transition metal compound pe e of the present invention
A prefened novel transition metal compound in accordance with the present has the Formula
Figure imgf000047_0001
Z is specifically an imidazole-containing group of formula:
Figure imgf000047_0002
wherein R R8, R9, R10 and Rπ are independently hydrogen or a monovalent (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups, (vi) heterosubstituted derivatives of said groups (i) to (v), and (vii) hydrocarbyl-substituted heteroatom groups. These defined groups preferably contain 1 to 30, more preferably 2 to 20, most preferably 2 to 12 carbon atoms. Examples of suitable aliphatic hydrocarbon groups are methyl, ethyl, ethylenyl, butyl, hexyl, isopropyl and tert-butyl. Examples of suitable alicyclic hydrocarbon groups are adamantyl, norbornyl, cyclopentyl and cyclohexyl. Examples of suitable aromatic' hydrocarbon groups are phenyl, biphenyl, naphthyl, phenanthryl and anthryl. Examples of suitable alkyl substituted aromatic hydrocarbon • groups are benzyl, tolyl, mesityl, 2,6-diisopropylphenyl and 2,4,6-triisopropyl. Examples of suitable heterocyclic groups are 2-pyridinyl, 3-pyridinyl, 2-thiophenyl, 2- furanyl, 2-pyrrolyl, 2-quinolinyl. Suitable substituents for forming heterosubstituted derivatives of said groups R\ to Rπ are, for example, chloro, bromo, fluoro, iodo, nitro, amino, cyano, ether, hydroxyl and silyl, methoxy, ethoxy, phenoxy (i.e. -OC6H5), tolyloxy (i.e. -OC6H4(CH3)), xylyloxy, mesityloxy, dimethylamino, diethylamino, methylethylamino, thiomethyl, thiophenyl and trimethylsilyl. Examples of suitable heterosubstituted derivatives of said groups (i) to (v) are 2-chloroethyl, 2- bromocyclohexyl, 2-nitroρhenyl, 4-ethoxyphenyl, 4-chloro-2-pyridinyl, 4- dimethyl aminophenyl and 4-methylaminophenyl. Examples of suitable hydrocarbyl- substituted heteroatom groups are chloro, bromo, fluoro, iodo, nitro, amino, cyano, ether, hydroxyl and silyl, methoxy, ethoxy, phenoxy (i.e. -OC6H5), tolyloxy (i.e. - OC6H4(CH3)), xylyloxy, mesityloxy, dimethylamino, diethylamino, methylethylamino, thiomethyl, thiophenyl and trimethylsilyl. Any of the substituents Ri to π maybe linked to form cyclic structures. Substituents R2 to Rπ may also suitably be inorganic groups such as fluoro, chloro, bromo, iodo, nitro, amino, cyano and hydroxyl.
Further suitable imidazole-containing groups may be obtained by removal of substituent Ri, for example by deprotonation when Ri is hydrogen, to give formally monoanionic imidazole-containing groups. Ri is preferably hydrogen, an aliphatic hydrocarbon group, an aromatic hydrocarbon group or is removed to give a formally monoanionic benzimidazole group. R8 to Rπ are preferably hydrogen, an aliphatic hydrocarbon group or an aromatic hydrocarbon group.
M is preferably a metal selected from Groups 3 to 11 of the periodic table, more preferably selected from Sc, Ti, Zr, Hf, V, Nb, Ta, Cr, Mo, W, Mn and most preferably V and Cr. E is independently selected from divalent (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups, (vi) heterosubstituted derivatives of said groups (i) to (v), and (vii) hydrocarbyl-substituted heteroatom groups. Examples of suitable divalent group R are -CH2-, -CH CH2-, -CH2 CH2CH2-, 1,2-phenylene, tra72S-l,2-cyclopentane, trans-1,2- cyclohexane, 2,3-butane, 1 , 1 '-biphenyl, 1 , 1 '-binaphthyl, and -Si(Me)2-. It is prefened that E is an aliphatic or aromatic hydrocarbon group. More preferably E is -CH -.
D is a donor group, for example oxygen, sulfur, an amine, an imine or a phosphine. Preferably D is oxygen, sulfur, an amine of formula -N(R12)- or a phosphine of formula -P(R13)- wherein R12 and Rι3 are hydrogen or (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups, (vi) heterosubstituted derivatives of said groups (i) to (v), (vii) hydrocarbyl-substituted heteroatom groups and (viii) further imidazole- containing groups. Alternatively R12 or R13 may be removed, for example by deprotonation when they are hydrogen, to give a formally monoanionic fragments. More preferably D is an amine of formula -N(R1 )- as define above. R12 is preferably hydrogen, an aliphatic hydrocarbon, an aromatic hydrocarbon or a further imidazole containing group.
X is an anionic group and can be, for example, a halide, preferably chloride or bromide; or a hydrocarbyl group, for example, methyl, benzyl or phenyl; a carboxylate, for example, acetate or acetylacetate; an oxide; an amide, for example diethyl amide; an alkoxide, for example, methoxide, ethoxide or phenoxide. Alternatively, X can be a non-coordinating or weakly-coordinating anion, for example, tefrafluoroborate, a fluorinated aryl borate or a triflate. The anionic groups X may be the same or different and may independently be monoanionic, dianionic or trianionic. L is a neufral donor group and can be, for example, a solvate molecule, for example diethyl ether or THF; an amine, for example, diethyl amine, frimethylamine or pyridine; a phosphine, for example trimethyl phosphine or triphenyl phosphine; or an olefm, or a neutral, conjugated or nonconjugated diene, optionally substituted with one or more groups selected from hydrocarbyl or trimethylsilyl groups, said L having up to 40 carbon atoms and forming a .pi.-complex with M.
Values y and z are independently zero or integers such that the number of X and L groups satisfy the valency and oxidation state of the metal M. The value of y depends on the formal charge on each group Z and D, the charge on the anionic group X and the oxidation state of the metal M. For' example, if M is chromium in oxidation state +3, Z is a neufral groups and both D groups are neutral, then y is 3 if X is a monoanionic group (eg. chloride); if M is chromium in oxidation state +3, Z is a neutral group, one D group is monoanionic and the other D is neutral, then y is 2 if all X groups are monoanionic groups (e.g. chloride).
The invention is further illusfrated with reference to the following Examples. In the Examples all manipulations of air/moisture-sensitive materials were performed on a conventional vacuum inert atmosphere (nitrogen) line using standard Schlenk line techniques, or in an inert atmosphere glove box.
Example 1
Preparation of N,N-bis(lH-benzimidazol-2-ylmethyl)-N-methylamine (L-l)
Figure imgf000050_0001
A mixture of 4.00 g (27.2 mmol) N-methyliminodiacetic acid and 5.99 g (54.4 mmol) o-phenylene diamine in 30 ml ethylene glycol was stirred at 190°C for 4 hours. The water produced during was distilled off continuously. At the end of the reaction, the reaction mixture was allowed to cool down to room temperature and then poured in 150 ml water. The obtained slurry was triturated for 30 min, filtered, washed with water (3 x 30 ml) and dried at 60°C under reduced pressure for 48 hours. Yield 6.88 g (87.0%). IH NMR (250 MHz, DMSO-d6), δ 2.25 (s, 3H), 3.90 (s, 4H), 7.15 (m, 4H), 7.47-4.58 ( , 4H), 12.33 (br. s, 2H). Microanalysis, %: Calculated for C17H17N5,: C 70.10, H 5.84, N 24.05. Found: C 70.22, H 6.05, N 23.76. +CI MS (m/z): [292]. (+CI-MS is Positive Chemical Ionisation Mass Spectroscopy). Example 2
Preparation of [N,N-bis(lH-benzimidazol-2-ylmethyl)-N- methyl amine] trichlorochromium(πi) (Cr- 1 )
Figure imgf000051_0001
CM
A slurry of 0.50 g (1.72 mmol) L-l and 0.64 g (1.72 mmol) CrC13(THF)3 in 10 mL THF was stined at reflux for 5 hours. The obtained green solid was filtered, washed with THF (3 x 10 mL) and dried under reduced pressure. Yield 0.71 g (91.8%). Microanalysis,%: Calc. for C17H17N5CrC13: C 45.38, H 3.78, N 15.57. Found C 45.49, H 3.71, N 15.33. +FAB MS (m/z): M-Clj 413. μeff. = 3.73 BM. (THF is tetrahydrofuran; +FAB MS is Positive Fast Atom Bombardment Mass Spectroscopy; μeff. is magnetic moment.
Examples 3-11 (Table 1)
Ethylene oligomerization/polymerisation tests with Cr-1
The ethylene oligomerisation/polymerisation tests were canied out using the following procedure.
Preparation of solution of activated catalyst. The required amount of catalyst precursor Cr-1 (0.5 - 5 mg) was suspended in 20 - 100 ml toluene followed by the addition of the co-catalyst (methylalumoxane - MAO, 0.01 - 8 mmol). Thus prepared solution can be used immediately or stored at 0°C for a number of days. Ethylene oligomerisation / polymerisation.
The ethylene oligomerisation/polymerisation reactions were usually canied out in a 400 ml "Fischer-Porter" glass reactor equipped with a gas inlet, a catalyst inlet, a mechanical stiner and a digital thermometer. An aliquot of 1-5 ml of the catalyst solution described above was added to the reactor containing 200 - 300 ml solvent (usually toluene) and 0.1 - 5 mmol scavenger (usually frisobutyl aluminium - TIBAL or MAO). The reactor was then connected to the ethylene gas supply at the desired pressure and the temperature brought to the required value. The reaction was carried out for 10 - 120 min (usually 60 min). The reaction mixture was then quickly cooled down to room temperature (if necessary) and the reaction terminated by venting the ethylene off. GC (Gas Chromatography) samples were always withdrawn and analysed in order to determine the molecular- eight distribution of the C4-C40 olefins. The reactor content was then poured into a beaker containing 400 ml methanol and a few drops of 2M HCL. The precipitated polymer was filtered, washed with methanol and dried at 60°C under vacuum.
Figure imgf000052_0001
Notes
#1. MAO is methylalumoxane (co-catalyst)
#2. Temperature set-point is the temperature at the start of the polymerisation reaction.
The temperature in the reactor is uncontrolled and will change from this point due to the heat formation during the polymerisation reaction.
#3. ΔT is the difference between the temperature in the reactor and the temperature in the cooling bath
#4. This is the fraction of ethylene oligomers, soluble in toluene at room temperature.
#5. The fraction of ethylene oligomers insoluble in toluene at room temperature
#6. The activity is based on the sum of the soluble and insoluble fractions.
Example 11. In presence of 10 ml 1-hexene.
Gas Chromatography traces for the soluble fractions from Examples 3, 7, 8, 9 and 11 are shown in Figures 1, 2, 3, 4 and 5 of the drawings. The molecular weight distributions of the soluble fractions obtained by Crl c n be described by a combination of two distribution curves - a Schulz-Flory type curve for the Cn homologues and an intennediate (Schulz-Flory - Poisson) type curve for the
Cn+2 homologues.
The insoluble fraction consists of low molecular weight polyethylene. For example the insoluble fraction (polyethylene) described in Example 7 has Mn = 1298, Mw = 3537 and PDI = 2.62.
Example 12
Preparation of N,N-bis( 1 H-benzimidazol-2-ylmethyl)-N-benzylmine (L-2)
Figure imgf000053_0001
A mixture of 4.00 g (17.9 mmol) N-benzyliminodiacetic acid and 3.86 g (35 .8 mmol) o-phenylene diamine in 30 ml ethylene glycol was stirred at 190°C for 4 hours. The water produced during was distilled off continuously. At the end of the reaction, the reaction mixture was allowed to cool down to room temperature and then poured in 150 ml water. The obtained slurry was triturated for 30 min, filtered, washed with water (3 x 30 ml) and dried at 60°C under reduced pressure for 48 hours. Yield 4.94 g (75.0%). IH NMR (250 MHz, DMSO-d6), δ 3.72 (s, 2H), 3.92 (s, 4H), 7.13-7.57 (m, 13H), 12.37 (Br. s, 2H). +CI MS (m z): [368]. (+CI-MS is Positive Chemical Ionisation Mass Spectroscopy).
Example 13
Preparation of [N,N-bis(lH-benzimidazol-2-ylmethyl)-N- benzylamine]frichlorochromium(lTf) (Cr-2)
Figure imgf000054_0001
Cr2
A slurry of 1.00 g (2.82 mmol) L2 and 1.06 g (2.82 mmol) CrC13(THF)3 in 30 mL THF was stined at reflux for 4 hours. The obtained green solid was filtered, washed with THF (3 x 15 mL) and dried under reduced pressure. Yield 1.20 g (82.9%). Microanalysis,%: Calc. for C23H21N5CrC13: C 52.54, H 4.03, N 13.32. Found C 52.38, H 3.97, N 13.12. μeff. = 3.63 BM. (THF is tetrahydrofuran; Ueff. is magnetic moment).
Example 14
Ethylene oligomerisation/polymerisation test with catalyst Cr-2. Results are given in the Table.
Figure imgf000055_0002
The GC trace for the soluble fraction from Example 14 is shown in Figure 6 of the Drawings.
Example 15
Preparation of N,N-bis(7H-benzimidazol-2-ylmethyl)amine (L-3)
Ho2c
Figure imgf000055_0001
A mixture. of 3.62 g (27.2 mmol) N-iminodiacetic acid and 4.40 g (54.4 mmol) o-phenylene diamine in 30 ml ethylene glycol was stirced at 190°C for 4 hours. The water produced during was distilled off continuously. At the end of the reaction, the reaction mixture was allowed to cool down to room temperature and then poured in 150 ml water. The obtained slurry was triturated for 30 min, filtered, washed with water (3 x 30 ml) and dried at 60°C under reduced pressure for 48 hours. Yield 5.28 g (70.0%). 1H NMR (250 MHz, DMSO-d6), δ 3.40 (br.s, IH), 4.00 (s, 4H), 7.14 (m, 4H), 7.51 (m, 4H) 12.41 (br. s, 2H).
Preparation of [N,N-bis(lH-benzimidazol-2-ylmethyl)amine]trichlorochromium(lLT) (Cr-3)
Figure imgf000056_0001
Cr3
A slurry of 0.50 g (1.81 mmol) L3 and 0.68 g (1.81 mmol) CrCl3(THF)3 in 10 mL THF was stined at reflux for 4 hours. The obtained green solid was filtered, washed with THF (3 x 15 mL) and dried under reduced pressure. Yield 0.62 g (79.1%).
Example 16
Ethylene oligomerisation/polymerisation test with Cr-3
Figure imgf000056_0003
The GC trace for the soluble fraction from Example 16 is shown in Figure 7 of the Drawings.
Insoluble fraction: Mn = 807, Mw = 1316, PDI - 1.63.
Example 17
Preparation of N-methyl-N,N-bis[(l-methyl-lH-benzimidazol-2-yl)methyl]amine (L-4)
Figure imgf000056_0002
A mixture of 1.00 g (3.4 mmol) N,N-bis(lH-benzimidazol-2-ylmethyl)-N-methylamine, 0.33 g (13.8 mmol) ΝaH and 30 ml THF were stirred at room temperature for 30 min. Mel (0.43 ml, 6.8 mmol) was then added and the reaction mixture stined for another 4 hours. Addition of 120 ml water resulted in the formation of a off-white precipitate which was filtered, washed extensively with water and dried at 60°C under vacuum:. Yield 0.81 g (74.0%). 1H ΝMR (250 MHz, CDC13), δ 2.39 (s, 3H), 3.67 (s, 6H), 3.93 (s, 4H) 7.24 (m, 6H), 7.67 (m, 2H).
Example 18 Preparation of {N-methyl-N,N-bis[(l-methyl-lH-benzimidazol-2- yl)methyl]amine}frichloro-chromium(rπ) (Cr-4)
Figure imgf000057_0001
Cr4
A slurry of 0.50 g (1.56 mmol) L3 and 0.59 g (1.56 mmol) CrCl3(THF)3 in 20 ml THF was stirred at reflux for 4 hours. The obtained green solid was filtered, washed with THF (3 x 10 mL) and dried under reduced pressure. Yield 0.64 g (85.8%). Microanalysis, %: Calc. for C18H19Ν5CrCl3,: C 47.77, H 4.43, N 14.66. Found C 47.59, H 4.40, N 14.64.
Example 19 Ethylene oligomerisation/polymerisation test with Cr-4
Figure imgf000057_0002
The GC trace for the soluble fraction from Example 19 is shown in Figure 8 of the Drawings.
Insoluble fraction: Mn = 684, Mw = 999, PDI = 1.46.
Example 20
N,N,N-tris(iH-benzimidazol-2-ylmethyl)amine (L5)
Prepared as described in L. K. Thompson et al, Can J. Chem., 55 (1977), 878. ]H NMR
(250 MHz, DMSO-d6), δ 4.01 (s, 6H), 7.12 (m, 6H), 7.49 (m, 6H) 12.44 (br. s, 3H).
Preparation of { [N,N,N-tris(iH-benzimidazol-2-ylmethyl)amine]dichlorochromim (HI)} chloride (Cr-5)
Figure imgf000058_0001
Prepared as described in A. E. Cencieros-Gomes, Polyhedron, 19 (2000), 1821. +FAB MS (m/z): 531.
Ethylene oligomerisation/polymerisation test with Cr-5. The conditions are shown in the Table.
Figure imgf000058_0002
The GC trace for the soluble fraction from Example 20 is shown in Figure 9. Insoluble fraction: Mn = 800, Mw = 1200, PDI = 1.50 Examples 21-23
Ethylene oligomerisation/polymerisation test with Cr-5.
The conditions are shown in the following Table.
Figure imgf000059_0001
Note 1. PMAO (polymethylalumoxane) is obtained by removing the present trimethylaluminum in the commercial methylalumoxane by distillation under reduced pressure followed by washing with n-heptane. MMAO (modified methylalumoxane) contains triisobutalaluminium and is commercially supplied as solution in hexanes. Example 23. In presence of ethylene (1 bar) and propylene (2 bar). GC curves for the soluble fractions in Example 21 are shown in Figure 10; for Example 22 in Figure 11 and for Example 23 in Figure 12. Example 24
[N,N-bis(lH-benzimidazol-2-ylmethyl)-N-methylamine]dichlorotetrahydrofurano- chromium (HI) hexafluoroantimonate (Cr-6).
Figure imgf000060_0001
Cr6
A slurry of silver hexafluoroantimonate (0.62 g, 1.82 mmol) [N,N-bis(lH-benzimidazol- 2-ylmethyl)-N-methylamine]trichlorochromium(πi) (Crl) (0.50 g, 1.11 mmol) in 50 ml THF was stined at room temperature for 48 hours. The solution was filtered and the solvent removed under reduced pressure. Yield 0.33 g (53.0 %). +FAB MS (m/z): [413]. -FAB MS (m z): [237].
Example 25
Ethylene oligomerisation/polymerisation test with Cr-6
Figure imgf000060_0002
Example 26
Preparation of [N,N-bis(lH-benzimidazol-2-ylmethyl)-N-methylamine]-2,4- pentanedionatodichloro-chromium (HI) hexafluoroantimonate (Cr-7)
Figure imgf000061_0001
Cr7
Silver acetylacetonate (0.1 lg, 0.55 mmol) and [N,N-bis(lH-benzimidazol-2-ylmethyl)- N-methylamine]dichlorotetrahydrofurano-chromium (III) hexafluoroantimonate (Cr6) (0.40 g, 0.55 mmol) were dissolved in THF and stined at room temperature for 48 hours. After filtering, the solvent was removed, the residues re-dissolved in dichloromethane, filtered and layered with pentane to afford suitable crystals for X-ray diffraction. Yield 0.32 g (82.0 %). Microanalysis, %: Calc. for C22H23ClCrF6Ν5O2Sb: C 37.0, H 3.23, N 9.83. Found C 36.68, H 3.36, N 9.57. +FAB MS (m/z): [477]. -FAB MS (m/z): [235].(-FAB MS is Negative Fast" Atom Bombardment Mass Spectroscopy).
The molecular structure of complex Cr-7 is shown in Figure 13 of the Drawings Example 27
Ethylene oligomerisation polymerisation test with catalyst complex Cr-7
Figure imgf000061_0002
Example 28
Preparation of 2-Amino-3,6-dibromophenylamine
Figure imgf000062_0001
A mixture of 4,7-dibromo-2,l,3-benzothiadiazole (synthesized according to as described in K. Pilgram, J. Heterocycl. Chem., 7 (1970), 629) (16.0 g, 54.4 mmol) and NaBH4 (38.1 g, 1.0 mol) in 500 ml ethanol was stined at room temperature for 30 hours. The solvent was evaporated and the residue mixed with 500 ml water. The obtained mixture was extracted into diethyl ether (5 x 150 ml). The combined extracts were washed with brine (2 x 100 ml) and dried over anhydrous Na2SO4. Evaporation of the solvent and drying under reduced pressure afforded 11.5 g (79.5 %) of the product. Example 29
1 , r :4', l"-Te henyl-2',3 '-diamine
Figure imgf000062_0002
To a solution of 3.60 g (13.5 mmol) 2-amino-3,6-dibromophenylamine inl35 ml degassed benzene was added a solution 4.95g (40.6 mmol) phenylboronic acid in 30 ml ethanol, followed by 54 ml 2M aqueous Na2CO3 and 1.89 g (1.62 mmol) solid Pd(PPh3)4. The dark-blue reaction mixture was refluxed for 24 hours and then allowed to cool down to room temperature. The aqueous layer was decanted and washed twice with 20 ml ethyl acetate. The combined organic layers were washed with water (2 x 50 ml), dried over anhydrous Na2SO4 and evaporated. The residue was purified by flash chromatography (SiO2, 20% EtOAc / 80% n-hexane). Yield - 1.6 g (45.4 %). 1H NMR (250 MHz, CDC13), δ, ppm: 3.63 (br. S. 4H), 6.81 (s, 2H), 7.39 (m, 2H), 7.50 (m, 8H). Example 30
Preparation of l-(4,7-Diphenyl-lH-benzimidazol-2-yl)ethanol
Figure imgf000063_0001
A mixture of 1.25 g (4.8 mmol) l,l\^l erphenyl-2^3'-diamme, 0.75 ml (8.6 mmol) 85% aq. lactic acid and 4.8 ml 4N HC1 were stirred at reflux for 6 hours and then the volatile materials evaporated over lhour. The oily residue was heated to 140°C and stined for 15 min. After cooling to room temperature 10 ml water were added and the mixture triturated for 30 min. Addition of cone. NH4OH to pH~7.5-8 followed by filtration, washing with water (4 x 10 ml) and drying under vacuum at 60°C gave 1.25g (82.8 %) of the desired product. 1H NMR (250 MHz, CDC13), δ, ppm: 1.58 (d, JHH = 6.1 Hz, 3H), 3.64 (br.s, IH), 5.07 (q, IH), 7.37-7.76 (m, 12 H), 9.53 (br. s, IH). Example 31 Preparation of l-(4,7-Diphenyl-lH-benzimidazόl-2-yl)ethanone
Figure imgf000063_0002
A solution of 1.38g (4.7 mmol) potassium dichromate in 8.5 ml 40% H2SO4 was added dropwise to a stined suspension of 1.1 Og (3.5 mmol) 1 -(4,7-diphenyl- lH-benzimidazol- 2-yl)ethanol in 15 ml 5% H2SO4. The slurry was stined at 90°C for 10 hours, cooled to room temperature and treated with 7 ml cone. NH4OH. The residue was filtered, washed with water (5 x 10 ml) and extracted with acetone (10 x 30 ml). The combined extracts were filtered trough a 0.5 cm layer of silica and the filtrate evaporated. The residue was re-crystallized from ethyl acetate-cyclohexane. Yield - 0.57g (52.1%). 1H NMR (250 MHz, CDC13), δ, ppm: 2.83 (s, 3H), 7.44-7.64 (m, 10H), 8.14 (d, 7.6 Hz, 2H), 10.22 (br.s).
Example 32
Preparation of N-[(lE)-l-(4,7-dipheny-lH-benzimidazol-2-yl)ethylidene]-N-(2,6- isopropylphenyl)-amine
Figure imgf000064_0001
A mixture of 0.25g (0.8 mmol) l-(4,7-diphenyl-lH-benzimidazol-2-yl)ethanone, 0.6 ml diisopropyl aniline and a drop of glacial" acetic acid was stined at 150°C for 4 hours. The unreacted aniline was removed at 150°C under reduced pressure, the residual oil cooled to room temperature and triturated with 5 ml pentane at room temperature for 20 min. The mixture was then cooled to -20°C, triturated for another 5 min. and filtered while cold. The solid was washed with cold (-5°C) pentane (2 x 2 ml) and dried under reduced pressure. Yield - 0.28 g (74.2%).' Microanalysis, %: Calc. for C33H33N3: C 84.08, H 7.26, N 8.65. Found C 84.10, H 7.14, N 8.71. Η NMR (250 MHz, CDCI3), δ, ppm: 1.15 (dd, IHH = 3.1 Hz, HH =7.1 Hz, 12 H), 2.36 (s, 3H), 2.76 (m, 2H), 7.17 (m, 3H), 7.53 (m, 8H), 7.72 (dd, IHH = 1.5 Hz, JHH =6.9 Hz, 2H), 8.20 (dd, JHH = 1.2 Hz, JHH =7.0 Hz, 2H), 10.42 (br.s IH). Example 33
Preparation of N-(2,6-diisopropylphenyl)-N-[( 1 E)- 1 -( 1 -methyl-4,7-diphenyl- 1 H- benzimidazol-2-yl)ethylidene]amine (L-6)
Figure imgf000065_0001
A mixture of 0.25 g (0.53 mmol) N-[(lE)-l-(4,7-dipheny-lH-benzimidazol-2- yl)ethylidene]-N-(2,6-isopropylphenyl)-amine, 0.41 g (3.0 mmol) anhydrous K2CO3 and 0.08 g (0.56 mmol) Mel in 4 ml anhydrous DMF was stined at room temperature for 10 hours. The reaction mixture was then poured into 50 ml water, stined for 10 min and extracted with ethyl acetate (3 30 ml). The combined extracts were washed with water (3 x 15 ml) and dried over anhydrous Νa2SO4. The solvent was evaporated to give an yellow oil which was triturated with 5 ml methanol at -78°C, filtered while cold, washed with cold (-78°C) methanol (2 x 2 ml) and dried under reduced pressure. Yield 0.16 g (62.2 %). 1H NMR (250 MHz, CDC13), δ, ppm: 1.14 (dd, JHH = 7.0 Hz, JHH =15.0 Hz, 12 H), 2.38 (s, 3H), 2.75 (m, 2H), 3.87 (s, 3H) 7.14 (m, 3H), 7.29 (d, 7.6 Hz, IH), 7.53 (m, 9H), 7.72 (dd, JHH = 1-5 Hz, JHH =6.9 Hz, 2H), 8.19 (dd, JHH = 1.2 Hz, JHH =7.1 Hz, 2H).
Example 34
Preparation of {N-(2,6-diisopropylphenyl)-N-[(lE)-l-(l-methyl-4,7-diphenyl-lH- benzimidazol-2-yl)ethylidene]amine}dibromonickel (II). (Νi-1)
Figure imgf000065_0002
A slurry of 0.07g (0.14 mmol) N-(2,6-diisoproρylphenyl)-N-[(lE -l-(l-methyl-4,7- diphenyl-lH-benzimidazol-2-yl)ethylidene] amine and nickel dibromide dimethoxy ethane complex (0.04 g ( 0.14 mmol) in 5 ml dichloromethane (DCM) was stirred at room temperature for 24 hours. The solid was filtered, washed with DCM (3 x 5 ml) and dried under reduced pressure. Yield 0.09 g (88.7 %). The crystal structure of Nil is shown in Figure 14. Example 35
Ethylene polymerisation test with Ni-1
Figure imgf000066_0002
Example 36
Preparation of l-(lH-benzimidazol-2-yl)ethanone
As described in J. Kollonicsch, US Pat. 3,320 273 /l 6.5.1967.
Figure imgf000066_0001
A solution of 16.2 g (0.1 mol) l-(lH-benzimidazol-2-yl)ethanol (synthesised according to as described in A. atrizky et al. Tetrahedron Assymetry, 8 (1997), 1491) in 200 ml 5% H2SO4 was treated with a solution of 39.6g (75.5 mmol) potassium dichromate in 40% sulphuric acid. The reaction mixture was stined at room temperature for 18 hours and neutralised with 190 ml cone. NH4OH. The formed precipitate was filtered, washed with 700 ml water and extracted with 700 ml 96% ethanol. The solvent was evaporated to c.a. 50-80 ml, the formed suspension cooled to -40°C, stirred for 10 min and filtered while cold. The solid was washed with 2x 10 ml cold ethanol and dried under reduced pressure. Yield - 9.3 g (58.1 %). 1H NMR (250 MHz, CDC13), δ, ppm: 2.84 (s, 3H), 7.38 (m, 2H), 7.56 (d, JHH = 7.3 Hz, IH), 7.89 (d, JHH = 7.6 Hz, IH), 11.08 (br.s IH). Example 37
Preparation of N-[( LEV 1 -( lH-benzimidazol-2-yl)ethylidene]-N- 1 , 1 ' :3 ", 1 "-terphenyl-2'- ylamine
Similarly to the method described in M. Ali et. al., Z Naturforsch. B. Anorg. Chem. Org.
Chem., 31 (1976), 254
Figure imgf000067_0001
A mixture of 0.8 g (3.26 mmol) l-(lH-benzimidazol-2-yl)ethanone, 0.52g (3.26 mmol) 2,6-diphenylaniline, 0.45g (3.75 mmol) tetraethylorthosilicate [(EtO) S] and 1 drop cone, sulfuric acid was stirred at 140°C for 16 hours. The volatile materials were evaporated, the residue cooled to room temperature and 5-6 ml methanol were added. The precipitate was filtered, washed with 5 ml cold methanol and extracted into 20 ml dichloromethane. The extract was filtered and the filtrate evaporated to give 1.2 g (76.3 %) of the desired product. Microanalysis, %: Calc. for C27H2ιN3: C 83.69, H 5.46, N 10.84. Found C 83.79, H 5.52, N 10.68. 1H NMR (250 MHz, CDC13), δ, ppm: 1.97 (s, 3H), 2.74 (m, 2H), 7.22 (m, 8H), 7.36 (m, 8H), 7.75 (JHH = 7.3 Hz, IH), 10.0 (br.s, IH). Example 38
Preparation of N-[(lE)-l-(l-benzyl-lH-benzimidazol-2-yl)ethylidene]-N-l,l':3',l"- terphenyl-2'-ylamine (L-7)
Figure imgf000067_0002
A mixture of 0.70 g (1.87 mmol) N-[(lE)-l-(lH-benzimidazol-2-yl)ethylidene]-N- l,l':3^1'Aeφhenyl-2'-ylamine, 1.42 g (10.3 mmol) anhydrous K2CO3 and 0.35 g (2.06 mmol) benzylbromide in 4 ml anhydrous DMF was stirred at room temperature for 10 hours. The reaction mixture was then poured into 80 ml water, stirred for 10 min and extracted with ethyl acetate (3 x 50 ml). The combined extracts were washed with water
(3 x 25 ml) and dried over anhydrous Na2SO4. The solvent was evaporated to give an yellow oil which was triturated with 5 ml methanol at -78°C, filtered while cold,' washed with cold (-78°C) methanol (2 x 2 ml) and dried under reduced pressure. Yield
0.56 g (66.2 %). 1H NMR (250 MHz, CDC13), δ, ppm: 2.07 (s, 3H), 5.51 (m, 2H), 6.90
(m, 2H) 7.22 (m, 19H), 7.78 (m, IH).
Example 39
Preparation of {N-[( IE)- 1 -( 1 -benzyl- lH-benzimidazol-2-yl)ethylidene] -N- 1 , 1 ' : 3 ', 1"- terρhenyl-2'-ylamine}dibromonickel (II) (Νi-2)
Figure imgf000068_0001
A slurry of 0.30g (0.65 mmol) N-[(lE)-l-(l-benzyl-lH-benzimidazol-2-yl)ethylidene]- N-l,1^3^1 eφhenyl-2'-ylamine and nickel dibromide dimethoxy ethane complex (0.19 g, 0.65 mmol) in 20 ml dichloromethane (DCM) was stined at room temperature for 24 hours. The solid was filtered, washed with DCM (3 x 10 ml) and dried under reduced pressure. Yield 0.40 g (90.2 %).
Examples 40-42
Ethylene oligomerisation tests with Ni-2 - See Table below
Figure imgf000069_0001
Examples 40-42 - Oligomer analvsis
Figure imgf000069_0002
Example 43
Preparation of 4,7-Diphenyl- lH-benzimidazole-2-carbaldehyde
Figure imgf000070_0001
A solution of 11.1 ml (27.72 mmol) n-BuLi (2.5 M in hexanes) was added dropwise to a cooled to -78°C solution of 3.4 g (13.2 mmol) l,r:4',r,-teφhenyl-2,,3'-diamine in 110 ml THF. The reaction mixture was stined at -78oC for 1 hour and 2.4 ml (13.5 mmol) dry ethyl diethoxyacetate were added dropwise over 1 min. The solution was then stined at 78°C for 30 min, allowed to slowly warm up room temperature, stined for another 30 min and the heated at reflux for 2 hours. Formation of white precipitate (LiOH) was observed during the reflux. After cooling to room temperature and addition of 60 ml water the reaction mixture was carefully neutralized with the addition of 5N acetic acid. Diethyl ether (200 ml) was then added, the formed biphasic mixture was vigorously stined and the organic layer separated. It was washed with water (3 x 100 ml) and dried over anhydrous sodium sulfate. Evaporation of the solvent afforded an yellow-brown oil which was dissolved in 15 ml THF and 60 ml 4N HC1 were added. The mixture was stirred at reflux for 2 hours, cooled to room temperature and 120 ml icy water was added. The mixture was stined vigorously for 10 min at ~0°C and then filtered. The solid was suspended in 70 ml water and neutralized with 10% aqueous sodium carbonate. The solid was filtered again, washed with water and dried at room temperature under reduced pressure. Yield - 2.85 g (72.4%). 1H NMR (250 MHz, CDC13), δ, ppm: 7.54 (m, 10H), 8.03 (br. s, 2H), 10.06 (s, IH), 10*.31 (br. s, IH). Example 44 Preparation of 1 -Methyl-4,7-diphenyl-lH-benzimidazole-2-carbaldehyde
Figure imgf000070_0002
A mixture of 3.3 g (11.07 mmol) 4,7-diphenyl-lH-benzimidazole-2-carbaldehyde, 8.60 g (62.0 mmol) anhydrous K2CO3 and 1.1 ml (11.07 mmol) dimethyl sulfate in 30 ml anhydrous DMF was stined at room temperature for 30 min. The reaction mixture was then poured into 300 ml water, stined for 10 min and extracted with dichloromethane (3 x 100 ml). The combined exfracts were washed with water (3 x 50 ml) and dried over anhydrous Na2SO4. The solvent was evaporated to give an yellow oil which was triturated with 20 ml methanol at 0°C, filtered while cold, washed with cold (0°C) methanol (2 x 10 ml) and dried under reduced pressure. Yield 3.1 g (89.6 %). Η NMR (250 MHz, CDC13), δ, ppm: 3.74 (s, 3H), 7.47 (m, 10H) 8.04 (d, JHH= 7.8 Hz, 2H), 10.1 (s, lH). Example 45
Preparation of N-(2,4-dimethoxybenzyl)-N-[(lE)-(l-methyl-4,7-diphenyl-lH- benzimidazol-2-yl)methylene] amine (L8)
Figure imgf000071_0001
A mixture of O.lg (0.32 mmol) l-methyl-4,7-diphenyl-lH-benzimidazole-2- carbaldehyde, 55 mg (0.32 mmol) 2,4-dimethoxybenzylamine and 1 drop glacial acetic acid in 8 ml methanol were stined for 12 hour at room temperature. The reaction mixture was cooled to -20°C and filtered while cold. The solid was washed with cold (- 20°C) methanol (2 x 1 ml) and dried at reduced pressure. Yield - 0.12g ( 81.1%). %). 1H NMR (250 MHz, CDC13), δ, ppm: 3.76 (s, 3H), 3.80 (s, 6H), 4.81 (s, 2H), 6.46 (m, 2H), 7.14. (d, JHH= 8.8 Hz, IH), 7.25 (d, JHH= 7.6 Hz, IH), 7.46 (m, 9H), 8.02 (d, JHH= 7.0 Hz, 2H), 8.61 (s, IH). Example 46
Preparation of {N-(2,4-dimethoxybenzyl)-N-[(lE)-(l-methyl-4,7-diphenyl-lH- benzimidazol-2-yl)methylene] amine }trichlorochromium (HI) (Cr-8).
Figure imgf000072_0001
A solution of 47 mg (0.1 mmol) N-(2,4-dimethoxybenzyl)-N-[(lE)-(l-methyl-4,7- diphenyl-lH-benzimidazol-2-yl)methylene]amine and 36 mg (0.1 mmol) tris(tefrahydro- furan)chromium trichloride in 5 ml THF was stirred at room temperature for 24 hours. The volume of the reaction mixture was reduced to c.a. 1 ml and 10 ml n-pentane were added. The formed precipitate was filtered, washed with pentane (2 x 2 ml) and dried under reduced pressure. Yield - 44 mg (72.0 %). Example 47 Ethylene polymerisation test with Cr-8
Figure imgf000072_0002
Example 47 - polymer properties
Ex. Mn Mw PDI
47 1421 52600 37.0
Example 48
Preparation of [N,N-bis(lH-benzimidazol-2-ylmethyl)-N- methylamine]frichlorovanadium(m) (V-l)
Figure imgf000073_0001
V-1
A slurry of 12.00 g (41.2 mmol) L-l and 15.4 g (41.2 mmol) VC13(THF)3 in 120 mL THF was stined at reflux for 30 min. The reaction mixture was then allowed to cool down to room temperature and stined for another 4 hours. The obtained yellow-green 5 solid was filtered, washed with THF (4 x 70 mL) and dried under reduced pressure. Yield 17.8 g (96.2%). Microanalysis,%: Calc. for C17H17N5VC13: C 45.51, H 3.82, N 15.61. Found C 45.39, H 3.62, N 15.41. FT-TR (KBr): 3244, 1596,' 1210, 1049, 1003, 982, 944, 752, 701, 653, 621, 518, 475, 455, 432, 416. Deff. = 2.89 BM. Examples 48-61
10 Ethylene homopolymerisation with V- 1
The ethylene homopolymerisation tests-were carried out using a procedure similar to that described in Example 3 -11.
Solution of activated catalyst:
The required amount of catalyst precursor V-1 (0.5 - 5 mg) was suspended in 20 - 100
15 ml toluene followed by the addition of the co-catalyst (DEAC - diethyl aluminium chloride or DMAC - diethylaluminium chloride - 0.1 - 10 mmol). Thus prepared solution can be used immediately or stored at 0°C for a number of days. Ethylene polymerisation
The ethylene polymerisation reactions were carried out either in a 400 ml "Fischer- 20 Porter" glass reactor (FPR) equipped with a gas inlet, a catalyst inlet, a mechanical stiner and a digital thermometer or in a IL stainless-steel reactor (SSR) equipped with an integral system for control of reaction temperature, ethylene pressure and ethylene flow. An aliquot of 1-5 ml of the catalyst solution described above was injected in the reactor containing 200 - 300 (FPR) or 400- 800 (SSR) ml solvent (usually toluene, n-
25 hexane, n-heptane or isobutane), 0.1 - 2 mmol scavenger (usually DMAC) and 10 -60 μmol reactivator (usually ethyl trichloroacetate - ETA or another chlorinated compound as chloroform). The reactor was then connected to the ethylene gas supply at the desired pressure and the temperature brought quickly to the required value. The reaction was carried out for 10 - 120 min (usually 60 min). The reaction mixture was then cooled down to room temperature (if necessary) and the reaction terminated by venting the ethylene off. If toluene was used as a polymerisation medium, the reactor content was then poured into a beaker containing 400 ml methanol and a few drops of 2M HCL The polymer was filtered, washed with methanol (if necessary) and dried at 60°C under vacuum.
Figure imgf000074_0001
Polymer properties
Figure imgf000075_0001
Note 1 Me2AlCl = dimethylaluminium chloride - DMAC;
Run 51 : Et2AlCl (diethylaluminium chloride - DEAC) used as cocatalyst
Runs 53 - 61: the amount of Me2AlCl shown includes the amount of the scavenger (0.5 mmol)
Note 2 - ECA = ethyl trichloroacetate - C2H5OC(O)CCl3
Note 3 - Temperature left uncontrolled during the polymerisation reaction. The change is due to the heat formation during the polymerisation reaction.
Examples 62-69
Ethylene copolymerisation with V-1
'The ethylene copolymerisation tests were carried out using a procedure similar to that described in Example 48 - 61. The required amounts of comonomer were preloaded in the polymerisation reactor.
Table V-IC. Polymerisation in toluene. Fisher-Porter glass reactor.
Figure imgf000076_0001
Polymer properties
Figure imgf000076_0002
Note l
ETA = ethyl trichloroacetate- C2H5OC(O)CCl3
Note 2
C3H6 = propene; 1-H = 1-hexene; NB = norbornene (2,2,l-bicyclohept-2-ene).
Note 3 - Temperature left uncontrolled during the polymerisation reaction. The change is due to the heat formation during the polymerisation reaction.
Example 70
[N)N-bis(lH-benzimidazol-2-ylmethyl)-N-methylamine]dipropoxyoxovanadium(V) (V-
2)
Figure imgf000077_0001
V-2
A cooled to -78°C solution of 0.42 g (1.72 mmol) tripropoxyoxovanadium (V) in 10 ml THF was added to a cold (-78°C) slurry of [N,N-bis(lH-benzimidazol-2-ylmethyl)-N- methylamine] in 20 ml THF. The mixture was allowed to warm up to room temperature and stined for 30 min. The orange-red solution was filtered to remove any traces of insoluble materials (ligand) and the filtrate evaporated to c.a. 5 ml. Addition of 50 ml pentane resulted in the formation of an orange solid which was filtered, washed with 2 x 5 ml pentane and dried under reduced pressure. Yield - 0.72g (88.0%). Microanalysis, %: Calculated for C23H30Ν5O3V: C 58.10, H 6.36, N 14.73. Found: C 57.93, H 6.26, N 14.77. 1H NMR (250 MHz, D2-DCM), δ: 0.85 (t, JHH= 14.7 Hz 6H), 1.62 (m, 4H), 2.85 (s, 3H), 3.08 (d, JHH= 15.9 Hz 2H), 4.02 (d, JHH= 16.2 Hz, 2H), 4.88 (dt, JHH= 13.4 Hz, JHH = 11.6 Hz, 2H), 5.34 (dt, JHH = 12.5 Hz, JHH= 11.3 Hz, 2H), 7.14 (m, 4H), 7.42 (m , 2H), 8.05 (m, 2H). 51V NMR [131 MHz, V(O)Cl3, d2-DCM], δ, ppm: -560.2.
The crystal structure of V-2 is shown in Figure 15. Examples 71-77
Ethylene homopolymerisation with V-2
The ethylene homopolymerisation tests were carried out using a procedure similar to . that described in Example 48-61
Table V-2H-FP. Polymerisation in toluene; Fisher-Porter glass reactor
Figure imgf000078_0001
catalyst solution aged for 7 hours; Example 74, activated catalyst solution aged for 27 hours.
Note 2 ECA = ethyl trichloroacetate - C2H5OC(O)CCl3
Note 3 Temperature left uncontrolled during the polymerisation reaction. The change is due to the heat formation during the polymerisation reaction.
Polymer properties
Figure imgf000078_0002
Table V-2H-SS. Polymerisation in heptane; Stainless steel reactor
Figure imgf000078_0003
Note 1 Me2AlCl = dimethylaluminium chloride - DMAC; the amount of Me2AlCl shown includes the amount of the scavenger (0.5 mmol)
Note 2 ECA = ethyl trichloroacetate - C2H5OC(O)CCl3 Polymer properties
Figure imgf000079_0002
Figures 16 and 17, respectively, show ethylene uptake as a function of time for Examples 77 and 78. Examples 78-81
Ethylene copolymerisation with V-2
The ethylene copolymerisation tests were canied out using a procedure similar to that described in Example 48 - 61. The required amounts of comonomer were preloaded in the polymerisation reactor. Table V-2C-FP. Polymerisation in toluene. Fisher-Porter glass reactor.
Figure imgf000079_0003
Note l ETA = ethyl trichloroacetate- C2H5OC(O)CCl3
Note 2 NB = norbornene (2,2,l-bicyclohept-2-ene); 1,9DD = 1,9-decadiene; EDE = 8- ethyltefracyclo-[4.4.0.12,5.17,10]-3-dodecene
Figure imgf000079_0001
Polymer properties
Figure imgf000080_0003
Example 86
Preparation of N-(2,4-dimethoxybenzyl)-N-[(l£)-(4,7-diphenyl-lH-benzimidazol-2- yl)methylene]-amine (L-9)
Figure imgf000080_0001
A mixture of O.l lg (0.37 mmol) 4,7-diphenyl- lH-benzimidazole-2-carbaldehyde and 56 mg 2,4-dimethoxybenzylamine in 3 ml methanol was stined at room temperature for 5 hours. The yellow precipitate was filtered, washed with cold (-20°C) methanol (3 x 1 ml) and dried under reduced pressure. Yield - 0.1 g (60.1 %).
Example 87
Preparation of {N-(2,4-dimethoxybenzyl)-N-[(lE)-(4,7-diphenyl- lH-benzimidazol-2- yl)methylene]-amine}frichlorovanadium (III) (V -3)
Figure imgf000080_0002
A solution of 81 mg (0.2 mmol) N-(2,4-dimethoxybenzyl)-N-[(lE)-(4,7-diphenyl-lH- benzimidazol-2-yl)methylene]amine and 64 mg (0.2 mmol) tris(tetrahydro- furan)vanadium trichloride in 5-6 ml THF was heated at reflux for 10 min, allowed to cool down and stirred at room temperature for 18 hours. The resulted slurry was mixed with 50 ml pentane and the formed precipitate filtered, washed with pentane (2 x 2 ml) and dried under reduced pressure. Yield - 75 mg (68.9 %). Examples 88-90
Ethylene homo- and copolymerisation with V-3
The ethylene copolymerisation tests were canied out using a procedure similar to that described in Example 48 - 61. The required amounts of comonomers were preloaded in the polymerisation reactor. Table V-3HC-FP. Polymerisation in toluene. Fisher-Porter glass reactor.
Figure imgf000081_0001
Note l ETA = ethyl trichloroacetate- C2H5OC(O)CCl3
Note 2 NB = norbornene (2,2,l-bicyclohept-2-ene); 1-H = 1-hexenePolymer properties
Figure imgf000081_0002
Example 91
Preparation of N-[(lE)-lH-benzimidazol-2-ylmethylene]-N-[2-
(trifluoromethyl)benzyl]amine (L-10)
Figure imgf000082_0001
A mixture of 1.1 g (7.5 mmol) lH-benzimidazole-2-carbaldehyde (Fluorochem), 1.3 g (7.5 mmol) 2-frifluoromethylbenzylamine and 1 drop glacial acetic acid in 10 ml methanol was stirred at room temperature for 72 hours. The resulted yellow solution was evaporated to c.a. 2-3 ml, cooled to -40°C and the formed solid filtered. It was washed with methanol/water mixture (1/2) and dried under reduced pressure. Yield - 1.96 g (86.4%). 1H NMR (250 MHz, D2-DCM), δ: 5.03 (s, 2H), 7.28-7.69 (m, 8H), 8.46 (s, IH).
Example 92
Preparation of {N-[(lE)-lH-benzimidazol-2-ylmethylene]-N-[2- (trifluoromethyl)benzyl]amine}tetra-hydrofuranotrichlorovanadium (III) (V-4)
Figure imgf000082_0002
A mixture of 0.40 (1.3 mmol) g N-[(lE)-lH-benzimidazol-2-ylmethylene]-N-[2- (trifluoromethyl)-benzyl] amine and 0.52 g (1.3 mmol) tris(tefrahydro-furan)vanadium trichloride in 40 ml THF was stined at room temperature for 3 hours. The volume of the reaction mixture was then reduced to c.a. 10 ml and 70 ml pentane were added. The formed precipitate was filtered, washed with 3 x 5 ml pentane and dried under reduced pressure. Yield - 0.62 g (89.6%).
Examples 93-94
Ethylene homo- and copolymerisation with V-4
The ethylene copolymerisation tests were carried out using a procedure similar to that described in Example 48 - 61. The required amounts of comonomers were preloaded in the polymerisation reactor.
Table V-4HCT-FP. Polymerisation in toluene. Fisher-Porter glass reactor.
Figure imgf000083_0001
Note l ETA = ethyl trichloroacetate- C2H5OC(O)CCl3
Note 2 NB = norbornene (2,2,l-bicyclohept-2-ene).
Figure imgf000083_0002
Example 96
Preparation of {N,N-bis(7H-benzimidazol-2-ylmethyl)-N- benzylamine}trichlorovanadium (ϋl) (V-5)
Figure imgf000084_0001
V-5
Analogously to Example 48, [N,N-bis(lH-benzimidazol-2-ylr ethyl)-N-benzylamine]- trichlorovanadium(iπ) (V-1) from l.Og (2.7 mmol) Ν,Ν-bis(/i -benzimidazol-2- ylmethyl)-N-benzylamine, 1.0 g (2.8 mmol) tris(tetrahydrofuran) vanadium trichloride and 40 ml THF. Yield 1.40 g (97.5 %). Microanalysis, %. C23H21N5C13V: C 52.64, H 4.0.3, N 13.35. Found: C 52.50, H 4.14, N 13.15. μeff. - 2.89 BM. Example 97
Ethylene homopolymerisation with V-5
The ethylene polymerisation tests were carried out using a procedure similar to that described in Example 48 - 61.
Table V-5H-FP. Polymerisation in toluene. Fisher-Porter glass reactor.
Figure imgf000084_0002
Note l ETA = ethyl trichloroacetate- C2H5OC(O)CCl3
Polymer properties
Example 98
Preparation of {N-methyl-N,N-bis[(l-methyl-lH-benzimidazol-2- yl)methyl] amine} trichloro-vanadium(ITI) ( V-6)
Figure imgf000085_0001
V-6
Analogously to Example 18 {N-methyl-N,N-bis[(l -methyl- lH-benzimidazol-2- yl)methyl]-amine}trichlorochromium (III) from 0.3 g (0.94 mmol) N-methyl-N,N-bis[(l- methyl-lH-benzimidazol-2-yl)methyl] amine, 0.35 g (0.94 mmol) tris(tetrahydrofuran)vanadium trichloride and 20 ml THF. Yield 0.30 g (67.0%). Microanalysis, %. Cι9H2ιΝ5Cl3V: C 4T-.87, H 4.44, N 14.69. Found: C 47.62, H 4.46, N 14.56
Example 99
Ethylene homopolymerisation with V-6
The ethylene polymerisation tests were carried out using a procedure similar to that described in Example 48 - 61.
Table V-6H-FP. Polymerisation in toluene. Fisher-Porter glass reactor.
Figure imgf000085_0002
Note l ETA = ethyl trichloroacetate- C2H5OC(O)CCl3 Polymer properties
Figure imgf000086_0002
Example 100
Preparation of [N,N-bis(lH-benzimidazol-2-ylmethyl)-N- benzylamine]dipropoxyoxovanadium(V) (V-7)
Figure imgf000086_0001
V-7
A cooled to -78°C solution of 1.65 g (6.8 mmol) tripropoxyoxovanadium (V) in 10 ml THF was added to a cold (-78°C) slurry of [N,N-bis(lH-benzimidazol-2-ylmetlιyl)-N- benzylamine] (2.50 g, 6.8 mmol) in 30 ml THF. The mixture was allowed to warm up to room temperature and stined for 30 min. The filtrate was evaporated to c.a. ID ml. The formed orange precipitate was filtered, washed with 2 x 10 ml pentane and dried under reduced pressure. Yield - l.lg (29.2.0%). 1H ΝMR (250 MHz, D2-DCM), δ: 0.91 (t, JHH = 14.9 Hz 6H), 1.69 (m, 4H), 2.93 (d, JHH= 15.5 Hz 2H), 4.25 (d, JHH = 15.6 Hz, 2H), 4.52 (s, 2H), 4.98 (m, 2H), 5.41 (m, 2H), 7.01 (m, 11H), 7.94 (d, JHH= 7.9 Kz , 2H), 8.05.
Example 101
Ethylene homopolymerisation with V-7
The ethylene polymerisation tests were carried out using a procedure similar to that described in Example 48 - 61 Table V-7H-SS. Polymerisation in heptane. Stainless steel reactor.
Figure imgf000087_0001
Note l ETA = ethyl trichloroacetate- C2H5OC(O)CCl3
Example 102
Preparation of supported on silica catalyst V-2. (V-2-SiO2)
To a slurry of 15 g silica 948, calcined at 250°C for 5h) in 150 ml toluene was added a solution 15 mg [N,N-bis(lH-benzimidazol-2-ylmethyl)-N-methylamine]dipropoxyoxo- vanadium(V) (Example 70) dissolved in 100 ml toluene. The slurry was stined at room temperature for 30 min, filtered, washed with pentane (3 x 100 ml) and dried at 40°C under vacuum. Thus prepared the solid catalyst contains 2.1 μmol V / SiO2.
Example 103
Ethylene homopolymerisation with V-2-SiO2
The ethylene polymerisation tests were carried out using a procedure similar to that described in Example 48 - 61. The solid catalyst was preactivated and fransferred in the reactor ia cannula . .
Table V-2-SiO2H-FP. Polymerisation in toluene. Fisher-Porter glass reactor.
Figure imgf000087_0002
Note l ETA = ethyl trichloroacetate- C2H5OC(O)CCl3 Example 104
Preparation of N,N,N-tris[l-hexyl-7H-benzimidazol-2-yl)methyl]amine
Figure imgf000088_0001
A mixture of 2g (4.9 mmol) N,N,N-tris(iH-benzimidazol-2-ylmethyl)amine, 10 g anhydrous K2CO3, 20 ml DMF and 3.1 g (14.7 mmol) n-hexyliodide was stirred at room temperature for 48 hours. A volume of 200 ml water was added and the resulting mixture was intensively stined for 30 min. The formed precipitate was filtered, washed with excess of water and dried at 60°C under reduced pressure. Recrystallisatipn from n- heptane gave 2g (62 %) of the product. IH NMR (250 MHz, CDCI3), δ, ppm: 0.44 (m, 6H), 0.73 (t, 9H), 0.82 (m, 6H), 0.97 (m, 6H), 1.14 (m, 6H), 3.42 (t, 6H), 4.22 (s, 6H), 7.22 (m, 9H), 7.74 (m, 3H).
Example 105
{N,N,N-tris[ 1 -hexyl-ii7-benzimidazol-2-yl)methyl]amine} dichlorochromium (HI) chloride (Cr-9)
Similarly to {[N,N,N-tris(/H-benzimidazol-2-ylmethyl)amine]dichlorochromim (HI)}- chloride from CrCl3.3THF and N,N,N-tris[l-hexyl-iH-benzimidazol-2- yl)methyl]amine} .
Yield - 54%. Example 106
Ethylene oligomerisation polymerisation test with Cr-9
Figure imgf000088_0002
Polymer properties
Figure imgf000089_0003
Example 107
Preparation of N,N-bis[( 1 -methyl- 7H-benzimi azol -2-yl)mefhyl] amine
H02C -NH C02H
Figure imgf000089_0001
A mixture of 2.7 g (20.3 mmol) methyliminodiacetic acid and 5.0 g (40.6 mmol) N- methyl-o-phenylene diamine in 20-30 ml ethylenediol was stined at 190°C for 4 hours. ix After cooling to room temperature, the reaction mixture was mixed with 100-120 ml water and stirred for 15 minutes. The solid was filtered, washed with water (3 x 20 ml) and dried at 60°C under reduced pressure. Yield - 3.5 g (56%). The compound can be recrystalised from a methanol/water mixture.
Example 108
{N,N-bis[(l -methyl-7H-benzimidazol-2-yI)methyl]amine}trichlorochromium (in) (Cr- 10)
Figure imgf000089_0002
Cr-10
Similarly to [N)N-bis(lH-benzimidazol-2-ylmethyl)-N-methylamine]trichloro- chrommm(JJI) (Cr-1) from 0.5 g (1.64 mmol) Ν,Ν-bis[(l-methyl-7H-benzimidazol-2- yl)methyl]amine, 0.61g (1.64 mmol) CrCl3.3THF and 20 ml THF. Yield - 0.39 g (51%). Example 109
Attempted ethylene oligomerisation polymerisation test with Cr-10
Figure imgf000090_0002
Example 110 [N,N-bis(7H-benzimidazol-2-ylmethyl)-N-benzylamine]dichloromanganese (Mn - 1)
Figure imgf000090_0001
Mn-1
A mixture of 0.50 g (1.41 mmol) N,N-bis(7H-benzimidazol-2-ylmethyl)-N-benzylamine and 0.18 g (1.41 mmol) MnCl2 was stined in 10 ml refluxing DCM for 10 min. The reaction mixture was then cooled to room temperature and stired for another 4 hours. The pale pink precipitate was filtered, washed with 2 x 5 ml DCM and dried under reduced pressure. Yield 0.48 g (69 %). Example 111-112
Attempted ethylene oligomerisation polymerisation test with Mn-1
Figure imgf000091_0003
Note 1
TIBAL = rriisobutyl aluminium
Example 113
2- { [( 1 H-benzimidazol-2-ylmethyl)thio]methyl} - 1 H-benzimidazole
H02C -C02H
Figure imgf000091_0001
A solution of 4.1 g (27.3 mmol) thiodiacetic acid and 4.9 g (27.3 mmol) o-phenylene diamine in 40 ml 4N HC1 was stirred at reflux for 4 hours. The reaction mixture was cooled to room temperature an neufralised with cone. NH4OH. The formed precipitate was filtered, washed with water (3 x 40 ml) and dried under vacuum. Yield - 2.4g (25.2 10 %).
Example 114
{2- { [( 1 H-benzimidazol-2-ylmethyl)thio]methyl } - 1 H-benzimidazole} trichloro- criromium (III) (Cr-11)
Figure imgf000091_0002
Cr-11 Similarly to [N,N-bis(lH-benzimidazol-2-ylmethyl)-N-methylamine]trichloro- chromium(ILT) (Cr-1) from 0.25 g (0.85 mmol) 2-{[(lH-benzimidazol-2- ylmethyl)thio]methyl}-lH-benzimidazole, 0.32g (0,85 mmol) CrCl3.3THF and 30 ml THF. Yield - 0.20 g (52.6%).
Example 115
Attempted ethylene oligomerisation/polymerisation test with Cr-10
Figure imgf000092_0002
Example 116
{2- { [( 1 H-benzimidazol-2-ylmethyl)thio]methyl } - 1 H-benzimidazole} trichlorotitanium 0 (m) (Ti-i)
Figure imgf000092_0001
Ti-1
Similarly to [N,N-bis(lH-benzimidazol-2-ylmethyl)-N-methylamine]trichloro- chromium(iπ) (Cr-1) from 0.50 g (1.70 mmol) 2-{[(lH-benzimidazol-2- ylme.thyl)thio]methyl}-lH-benzimidazole, 0.62g (1.70 mmol) TiCl3.3THF and 40 ml 5 THF. Yield - 0.41 g (54.8%).
Example 117
Ethylene polymerisation test with Ti-1
Figure imgf000093_0001
Comparative Example 1
Ethylene homopolymerisation with fripropoxyoxovanadium (V) - (PrO)3V=O
The ethylene polymerisation test was carried out using a procedure similar to that described in Example 48 - 61. 5 Table V-C1H-FP. Polymerisation in toluene. Fisher-Porter glass reactor.
Figure imgf000093_0002
Note l
ETA = ethyl trichloroacetate- C2H5OC(O)CCl3
Comparative Example 2
Ethylene homopolymerisation with vanadium trichloride - VC13
10 The ethylene polymerisation test was carried out using a procedure similar to that described in Example 48 - 61.
Table V-C2H-FP. Polymerisation in toluene. Fisher-Porter glass reactor.
Figure imgf000093_0003
Note l
ETA - ethyl trichloroacetate- C2H5OC(O)CCl3
Comparative Example 3
Ethylene homopolymerisation with bis(cyclopentadiene)vanadiumdichloride (IV)
(Cp2VCl2)
The ethylene polymerisation test was canied out using a procedure similar to that described in Example 48 - 61.
Table V-C3H-FP. Polymerisation in toluene. Fisher-Porter glass reactor.
Figure imgf000094_0002
Note l ETA « ethyl trichloroacetate- C2H5OC(O)CC13 Comparative Example 4 Ethylene homopolymerisation with the following complex:
Figure imgf000094_0001
The ethylene polymerisation test was canied out using a procedure similar to that described in Example 48 - 61.
Table V-C1H-FP. Polymerisation in toluene. Fisher-Porter glass reactor.
Figure imgf000094_0003

Claims

Claims:
1. A polymerisation catalyst comprising
(1) a fransition metal compound having the following Formula A, and optionally
(2) an activating quantity of a suitable activator,
Formula A
Figure imgf000095_0001
wherein Z comprises a five-membered heterocyclic grovtp, the five membered heterocyclic group containing at least one carbon atom, at least one nifrogen atom and at least one other hetero atom selected from nitrogen, sulphiur and oxygen, the remaining atoms in said ring being selected from nitrogen and carbon; M is a metal from Group 3 to 11 of the Periodic Table or a lanthanide metal; E1 and E2 are divalent groups independently selected from (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups and (vi) heterosubstituted derivatives of said groups (i) to (v); D1 and D2 are donor atoms or groups; X is an anionic group, L is a nexx.tral donor group; n = m = zero or 1; y and z are independently zero or integers such that the number of X and L groups satisfy the valency and oxidation state of the metal M.
2. A polymerisation catalyst as claimed in claim 1 wherein the five membered heterocyclic group contains at least 3 carbon atoms in its ring.
3. A polymerisation catalyst as claimed in claim 1 comprising
(1) a transition metal compound having the following Formula A, and optionally
(2) an activating quantity of a suitable activator,
Figure imgf000096_0001
Formula A
wherein Z is specifically an imidazole-containing group; M is a metal from Group 3 to
1 11 of the Periodic Table or a lanthanide-metal; E and E are divalent groups independently selected from (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups and (vi) heterosubstituted derivatives of said groups (i) to (v); D1 and D2 are donor groups; X is an anionic group, L is a neutral donor group; n = m = zero or 1 ; y and z are independently zero or integers such that the number of X and L groups satisfy the valency and oxidation state of the metal M.
4. A polymerisation catalyst as claimed in any one of Claims 1 to 3 wherein M is a metal from Group 3 to 7 of the Periodic Table or a lanthanide metal.
5. A polymerisation catalyst as claimed in any one of the preceding Claims wherein D1 and / or D2 are an imidazole-containing group.
6. A polymerisation catalyst as claimed in any one of Claims 3 to 5 wherein D2 and Z are identical imidazole containing groups.
7. A polymerisation catalyst as claimed in any one of Claims 3 to 6 wherein the imidazole-containing group Z is selected from a group of Formula I, It or HI
Figure imgf000097_0001
Formula I Fonnula II Formula III
R1 to R1 ' are independently hydrogen or a monovalent (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups, (vi) heterosubstituted derivatives of said groups (i) to (v), and (vii) hydrocarbyl-substituted heteroatom groups.
8. A polymerisation catalyst as claimed in Claim 1 wherein the a transition metal compound has the following Formula B or C
Formula C
Formula B
Figure imgf000097_0002
Figure imgf000097_0003
wherein the imidazole nucleus shown within the dotted circle is selected from the divalent groups represented by the Formulae la, Ha, Hla, IVa, Va and Via,
Figure imgf000097_0004
Figure imgf000098_0001
wherein M is a metal from Group 3 to 11 of the Periodic Table or a lanthanide metal; E1 and E2 are divalent groups independently selected from (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups and (vi) heterosubstituted derivatives of said groups (i) to (v); D1 and D2 are donor groups; X is an anionic group, L is a neutral donor group; n = m = zero .or 1 ; y and z are independently zero or integers such that the number of X and L groups satisfy the valency and oxidation state of the metal M, wherein the groups R2 to R11 are independently hydrogen or a monovalent (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups, (vi) heterosubstituted derivatives of said groups (i) to (v), and (vii) hydrocarbyl-substituted heteroatom groups.
9. A polymerisation catalyst as claimed in any one of the preceding Claims wherein E1 and E2 are independently selected from -CH2-, -CH2CH2-, -CH2 CH2CH2-, 1 ,2- phenylene, tr rø-.l,2-cyclopentane, trans- 1,2-cyclohexane, 2,3-butane, 1,1 '-biphenyl, 1,1 '-binaphthyl, and -Si(Me)2-.
10. A polymerisation catalyst as claimed in any one of Claims 1 to 4 or 8 wherein D1 and D are selected from oxygen, sulfur, an amine of formula -N(R )- or a phosphine of formula -P(R )- wherein R and R are hydrogen or (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups, (vi) heterosubstituted derivatives of said groups (i) to (v), (vii) hydrocarbyl-substituted heteroatom groups and (viii) an imidazole- containing group.
11. A polymerisation catalyst as claimed in any one of the preceding Claims wherein M is selected from Sc, Ti, Zr, Hf, V, Nb, Ta, Cr, Mo and W.
12. .A polymerisation catalyst as claimed in any one of the preceding Claims wherein the anionic group X is selected from a halide, a hydrocarbyl group, a carboxylate, an oxide; an amide; an alkoxide; an acetylacetonate; and a hydroxyl.
13. A polymerisation catalyst as claimed in any one Claims 1 to 11 wherein X is a non-coordinating or weakly-coordinating anion.
14. A polymerisation catalyst as claimed in any one of the preceding Claims wherein the neufral donor group L is selected from an ether, an amine, a phosphine, an olefm, water and a neutral, conjugated or nonconjugated diene,
15. A polymerisation catalyst as claimed in any one of the preceding Claims wherein the optional activator (2) is selected from organoaluminium compounds and organoboron compounds and mixtures thereof.
16. A polymerisation catalyst as claimed in Claim 15 wherein the optional activator (2) is selected from trimethylaluminium, triethylaluminium, tributylaluminium, tri-n- octylaluminium, ethylaluminium dichloride, diethylaluminium chloride, tris(pentafluorophenyl)aluminium, alumoxanes, dimethylphenylammoniumtetra(phenyl)borate, frityltetra(phenyl)borate, triphenylboron, dimethylphenylammonium tefra(pentafluorophenyl)borate, sodium tetrakis[(bis-3,5-trifluoromethyl)phenyl]borate, H+(OEt )[(bis-3,5- trifluoromethyl)phenyl]borate, trityltetra(pentafluorophenyl)borate and tris(pentafluorophenyl) boron.
17. A polymerisation catalyst as claimed in any one of the preceding Claims wherein the optional activator is provided by a Lewis acid selected from
(a) ionic-bonding compounds having a CdCl type or a Cdl2 type of layered crystal structure;
(b) clays, clay minerals, or ion-exchange layered compounds;
(c) heteropoly-compounds; and (d) halogenated lanthanoid compounds.
18. A polymerisation catalyst as claimed in any one of the preceding Claims wherein the optional activator is provided by a catalyst support-activator agglomerate comprising a composite of (A) at least one inorganic oxide component selected from SiO2, Al2O3, MgO, AlPO4, TiO2, ZrO2, and Cr O3 and (B) at least one ion containing layered material comprising a smectite.
19. A polymerisation catalyst as claimed in any one of the preceding Claims wherein there is present a promoter comprising a halogenated organic compound.
20. A polymerisation catalyst as claimed in Claim 19 wherein the promoter is selected from carbon tefrachloride, hexachloroethylene, benzylbromide, benzylchloride, ethyl trichloroacetate and 2,3- or 1,3-dichloropropylene, chloroform (CHC13) and n- butylchloride.
21. A polymerisation catalyst as claimed in Claim 20 wherein the transition metal is vanadium.
21. A polymerisation catalyst as claimed in any one of the preceding Claims wherein m and n are zero in Formula A so that the fransition metal compound is of Formula D
Figure imgf000100_0001
22. A polymerisation catalyst as claimed in any one of the preceding Claims wherein m and n are zero in Formula A so that the fransition metal compound is of Formula E or Formula F'
Figure imgf000100_0002
and wherein the imidazole nucleus within the dotted circle is selected from the divalent groups represented by the Formulae la, Ha, Hla, IVa, Va and Via as follows:
Figure imgf000101_0001
23. A polymerisation catalyst as claimed in any one of the preceding Claims wherein in addition to the defined catalyst there is present one or more other catalysts for polymerising 1 -olefins.
24. A polymerisation catalyst as claimed in any one of the preceding Claims wherein in addition to the defined catalyst there is present one or more other transition metal catalysts selected from Ziegler-Natta catalyst systems, metallocene-based catalysts, or heat activated supported chromium oxide catalysts.
25. A supported catalyst comprising the polymerisation catalyst defined in any one of the preceding Claims and a support material.
26. A process for the polymerisation and copolymerisation of 1 -olefins, cycloolefins or dienes, comprising contacting the monomeric olefin under polymerisation conditions with the polymerisation catalyst claimed in any one of the preceding Claims.
27. A process as claimed in Claim 26 wherein the process is for the homopolymerisation of 1 -olefins and wherein the monomer is selected from ethylene, propylene, butene, hexene, and styrene.
28. A process as claimed in Claim 26 wherein the process is for the copolymerisation of 1 -olefins and wherein the monomer is selected from ethylene, propylene, 1-butene, 1-hexene, 4-methylpentene-l, octane, methyl methacrylate, methyl acrylate, butyl acrylate, acrylonitrile, vinyl acetate, vinyl chloride, and styrene.
29. A process as claimed in Claim 26 comprising the copolymerisation of ethylene and or propylene with comonomers selected from 1-butehe, 1-hexene, 4-methylpentene-l, methyl methacrylate, methyl acrylate, butyl acrylate, acrylonitrile, vinyl acetate, and styrene, diene, cyclic olefm, norbornene and substituted norbornene.
30. A process as claimed in any one of Claims 26 to 29 wherein the catalyst is supported on a support material selected from silica, alumina, zirconia, talc, kieselguhr, magnesia, magnesium chloride and polymers.
31. A process as claimed in any one of Claims 26 to 30 wherein the process is carried out under gas phase, slurry phase or solution phase polymerisation conditions.
32. A process as claimed in any one of Claims 26 to 31 wherein the process is carried in the presence of hydrogen gas to modify the average molecular weight of the produced polymer.
33. A process for oligomerisation and cooligomerisation of 1-olefins, comprising contacting the monomeric olefin under oligomerisation conditions with the catalyst claimed in any one of Claims 1 to 25.
34. A polymerisation catalyst comprising
(1) a transition metal compound having the following Formula Al, and optionally (2) an activating quantity of a suitable activator,
Figure imgf000102_0001
wherein Z is specifically an imidazole-containing group; M is a metal from Group 3 to 7 of the Periodic Table or a lanthanide metal; E is a divalent group independently selected from (i) aliphatic hydrocarbon, (ii) alicyclic hydrocarbon, (iii) aromatic hydrocarbon, (iv) alkyl substituted aromatic hydrocarbon (v) heterocyclic groups and (vi) heterosubstituted derivatives of said groups (i) to (v); D is a donor group; X is an anionic group, L is a neutral donor group; y and z are independently zero or integers such that the number of X and L groups satisfy the valency and oxidation state of the metal M.
PCT/GB2004/001184 2003-03-20 2004-03-18 Polymerisation and oligomerisation catalysts WO2004083263A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP2006505990A JP5401011B2 (en) 2003-03-20 2004-03-18 Polymerization catalyst and oligomerization catalyst
BRPI0408549A BRPI0408549B1 (en) 2003-03-20 2004-03-18 catalysts and polymerization and oligomerization processes
EP04721578.5A EP1603957B1 (en) 2003-03-20 2004-03-18 Polymerisation and oligomerisation catalysts
KR1020057017626A KR101273309B1 (en) 2003-03-20 2004-03-18 Polymerisation and oligomerisation catalysts
US10/549,314 US7229943B2 (en) 2003-03-20 2004-03-18 Polymerisation and oligomerisation catalysts
AU2004222079A AU2004222079B2 (en) 2003-03-20 2004-03-18 Polymerisation and oligomerisation catalysts
CA2519854A CA2519854C (en) 2003-03-20 2004-03-18 Polymerisation and oligomerisation catalysts
MXPA05009958A MXPA05009958A (en) 2003-03-20 2004-03-18 Polymerisation and oligomerisation catalysts.
ZA2005/06886A ZA200506886B (en) 2003-03-20 2005-08-26 Polymerisation and oligomerisation catalysts

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0306430.0A GB0306430D0 (en) 2003-03-20 2003-03-20 Polymerisation and oligomerisation catalysts
GB0306430.0 2003-03-20

Publications (1)

Publication Number Publication Date
WO2004083263A1 true WO2004083263A1 (en) 2004-09-30

Family

ID=9955183

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2004/001184 WO2004083263A1 (en) 2003-03-20 2004-03-18 Polymerisation and oligomerisation catalysts

Country Status (15)

Country Link
US (1) US7229943B2 (en)
EP (1) EP1603957B1 (en)
JP (1) JP5401011B2 (en)
KR (1) KR101273309B1 (en)
CN (1) CN100491417C (en)
AR (1) AR043667A1 (en)
AU (1) AU2004222079B2 (en)
BR (1) BRPI0408549B1 (en)
CA (1) CA2519854C (en)
GB (1) GB0306430D0 (en)
MX (1) MXPA05009958A (en)
RU (1) RU2343162C2 (en)
TW (1) TWI359697B (en)
WO (1) WO2004083263A1 (en)
ZA (1) ZA200506886B (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005111099A1 (en) * 2004-05-12 2005-11-24 Ineos Europe Limited Ethylene copolymers
WO2006008438A1 (en) * 2004-07-15 2006-01-26 Ineos Europe Limited Polymerisation catalyst
WO2006012327A2 (en) * 2004-06-29 2006-02-02 Exxonmobil Research And Engineering Company Chromium complexes and their use in olefin polymerization
US7011924B2 (en) * 2003-07-30 2006-03-14 Hynix Semiconductor Inc. Photoresist polymers and photoresist compositions comprising the same
WO2006030193A1 (en) * 2004-09-14 2006-03-23 Ineos Europe Limited Polyolefins
WO2006048634A1 (en) * 2004-11-04 2006-05-11 Ineos Europe Limited Polymerisation catalysts
WO2006096881A1 (en) * 2005-03-09 2006-09-14 Exxonmobil Chemical Patents Inc. Methods for oligomerizing olefins
US7256296B2 (en) * 2004-09-22 2007-08-14 Symyx Technologies, Inc. Heterocycle-amine ligands, compositions, complexes, and catalysts
US20100022724A1 (en) * 2005-08-02 2010-01-28 Grant Berent Jacobsen Diene Polymerisation
US8076524B2 (en) 2006-02-03 2011-12-13 Exxonmobil Chemical Patents Inc. Process for generating alpha olefin comonomers
EP2567752A1 (en) 2011-09-08 2013-03-13 IFP Energies Nouvelles New nickel-based catalytic composition and method for oligomerising olefins using said composition
US8648000B2 (en) * 2006-10-31 2014-02-11 Ineos Commercial Services Uk Limited Diene polymerisation
US11697666B2 (en) 2021-04-16 2023-07-11 Gilead Sciences, Inc. Methods of preparing carbanucleosides using amides
US11767337B2 (en) 2020-02-18 2023-09-26 Gilead Sciences, Inc. Antiviral compounds
US12030903B2 (en) 2020-02-18 2024-07-09 Gilead Sciences, Inc. Antiviral compounds
US12054507B2 (en) 2020-02-18 2024-08-06 Gilead Sciences, Inc. Antiviral compounds

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8546128B2 (en) 2008-10-22 2013-10-01 Life Technologies Corporation Fluidics system for sequential delivery of reagents
US11951474B2 (en) 2008-10-22 2024-04-09 Life Technologies Corporation Fluidics systems for sequential delivery of reagents
US20120259117A1 (en) * 2009-06-19 2012-10-11 The Regents Of The University Of California Organo-metallic frameworks and methods of making same
CA2812294A1 (en) 2010-09-27 2012-06-21 The Regents Of The University Of California Conductive open frameworks
TW201245157A (en) * 2011-03-15 2012-11-16 Sumitomo Chemical Co Metal complex and organic electronic device comprising same
JP6012055B2 (en) 2011-09-07 2016-10-25 ダウ コーニング コーポレーションDow Corning Corporation Titanium-containing complex and condensation reaction catalyst, method for preparing the catalyst, and composition containing the catalyst
JP6066355B2 (en) 2011-09-07 2017-01-25 ダウ コーニング コーポレーションDow Corning Corporation Zirconium-containing complex and condensation reaction catalyst, method for preparing the catalyst, and composition containing the catalyst
WO2013043785A2 (en) 2011-09-20 2013-03-28 Dow Corning Corporation Nickel containing hydrosilylation catalysts and compositions containing the catalysts
EP2758413B1 (en) 2011-09-20 2018-03-07 Dow Corning Corporation Iridium containing hydrosilylation catalysts and compositions containing the catalysts
US9480977B2 (en) 2011-09-20 2016-11-01 Dow Corning Corporation Ruthenium containing hydrosilylation catalysts and compositions containing the catalysts
JP6166266B2 (en) 2011-10-04 2017-07-19 ダウ コーニング コーポレーションDow Corning Corporation Iron (III) -containing complex and condensation reaction catalyst, method for preparing the catalyst, and composition containing the catalyst
US9139699B2 (en) 2012-10-04 2015-09-22 Dow Corning Corporation Metal containing condensation reaction catalysts, methods for preparing the catalysts, and compositions containing the catalysts
US9073950B2 (en) 2011-12-01 2015-07-07 Dow Corning Corporation Hydrosilylation reaction catalysts and curable compositions and methods for their preparation and use
WO2015066693A1 (en) 2013-11-04 2015-05-07 The Regents Of Thd University Of California Metal-organic frameworks with a high density of highly charged exposed metal cation sites
US10287304B2 (en) 2014-02-19 2019-05-14 The Regents Of The University Of California Acid, solvent, and thermal resistant metal-organic frameworks
CN107148422A (en) 2014-03-18 2017-09-08 加利福尼亚大学董事会 The mesoscopic material of orderly superlattices comprising micropore metal organic backbone
WO2015195179A2 (en) 2014-03-28 2015-12-23 The Regents Of The University Of California Metal organic frameworks comprising a plurality of sbus with different metal ions and/or a plurality of organic linking ligands with different functional groups.
US9517658B2 (en) 2014-07-11 2016-12-13 American Axle & Manufacturing, Inc. Axle assembly with carrier housing having increased strength and reduced mass
US10118877B2 (en) 2014-12-03 2018-11-06 The Regents Of The University Of California Metal-organic frameworks for aromatic hydrocarbon separations
US10058855B2 (en) 2015-05-14 2018-08-28 The Regents Of The University Of California Redox-active metal-organic frameworks for the catalytic oxidation of hydrocarbons
JP2019503407A (en) 2015-11-27 2019-02-07 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Covalent organic structure having woven structure
KR102545533B1 (en) * 2016-05-27 2023-06-21 에스케이이노베이션 주식회사 Oligomerization Catalyst And Process For Preparing Ethylene Oligomer Using Thereof
WO2018208375A1 (en) * 2017-05-09 2018-11-15 Exxonmobil Chemical Patents Inc. Linear alpha olefin process including solvent purification using dividing wall distillation column
SG11202102679QA (en) 2018-09-18 2021-04-29 Nikang Therapeutics Inc Fused tricyclic ring derivatives as src homology-2 phosphatase inhibitors
CN112090447B (en) * 2019-06-17 2023-05-26 中国石油天然气股份有限公司 Alpha-diamido palladium catalyst and preparation method and application thereof
CN116970136B (en) * 2023-09-20 2024-02-09 山西大学 Benzimidazolyl covalent organic framework, preparation method and application thereof, proton conductor, and preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000219704A (en) * 1999-01-29 2000-08-08 Tosoh Corp Catalyst for olefin polymerization and preparation of polyolefin by using the same
WO2000069923A1 (en) * 1999-05-14 2000-11-23 The Dow Chemical Company Transition metal complexes and olefin polymerization process
US6281303B1 (en) * 1999-07-27 2001-08-28 Eastman Chemical Company Olefin oligomerization and polymerization catalysts
WO2001074831A1 (en) * 2000-03-31 2001-10-11 Polimeri Europa S.P.A. Complex polymerization catalysts for the homopolymerization of ethylene and for the copolymerization of ethylene

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000219704A (en) * 1999-01-29 2000-08-08 Tosoh Corp Catalyst for olefin polymerization and preparation of polyolefin by using the same
WO2000069923A1 (en) * 1999-05-14 2000-11-23 The Dow Chemical Company Transition metal complexes and olefin polymerization process
US6281303B1 (en) * 1999-07-27 2001-08-28 Eastman Chemical Company Olefin oligomerization and polymerization catalysts
WO2001074831A1 (en) * 2000-03-31 2001-10-11 Polimeri Europa S.P.A. Complex polymerization catalysts for the homopolymerization of ethylene and for the copolymerization of ethylene

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 2000, no. 11 3 January 2001 (2001-01-03) *

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7011924B2 (en) * 2003-07-30 2006-03-14 Hynix Semiconductor Inc. Photoresist polymers and photoresist compositions comprising the same
WO2005111099A1 (en) * 2004-05-12 2005-11-24 Ineos Europe Limited Ethylene copolymers
US7297805B2 (en) 2004-06-29 2007-11-20 Exxonmobil Research And Engineering Company Chromium complexes and their use in olefin polymerization
WO2006012327A3 (en) * 2004-06-29 2006-04-13 Exxonmobil Res & Eng Co Chromium complexes and their use in olefin polymerization
WO2006012327A2 (en) * 2004-06-29 2006-02-02 Exxonmobil Research And Engineering Company Chromium complexes and their use in olefin polymerization
US7498390B2 (en) * 2004-06-29 2009-03-03 Exxonmobil Research And Engineering Company Chromium complexes and their use in olefin polymerization
US7842638B2 (en) 2004-07-15 2010-11-30 Ineos Europe Limited Polymerisation catalyst
WO2006008438A1 (en) * 2004-07-15 2006-01-26 Ineos Europe Limited Polymerisation catalyst
WO2006030193A1 (en) * 2004-09-14 2006-03-23 Ineos Europe Limited Polyolefins
US7989565B2 (en) 2004-09-14 2011-08-02 Ineos Europe Limited Polyolefins
US7256296B2 (en) * 2004-09-22 2007-08-14 Symyx Technologies, Inc. Heterocycle-amine ligands, compositions, complexes, and catalysts
WO2006048634A1 (en) * 2004-11-04 2006-05-11 Ineos Europe Limited Polymerisation catalysts
WO2006099053A1 (en) * 2005-03-09 2006-09-21 Exxonmobil Chemical Patents Inc. Methods for oligomerizing olefins
WO2006096881A1 (en) * 2005-03-09 2006-09-14 Exxonmobil Chemical Patents Inc. Methods for oligomerizing olefins
US20100022724A1 (en) * 2005-08-02 2010-01-28 Grant Berent Jacobsen Diene Polymerisation
US8124698B2 (en) * 2005-08-02 2012-02-28 Ineos Europe Limited Diene polymerisation
US8076524B2 (en) 2006-02-03 2011-12-13 Exxonmobil Chemical Patents Inc. Process for generating alpha olefin comonomers
US8648000B2 (en) * 2006-10-31 2014-02-11 Ineos Commercial Services Uk Limited Diene polymerisation
EP2567752A1 (en) 2011-09-08 2013-03-13 IFP Energies Nouvelles New nickel-based catalytic composition and method for oligomerising olefins using said composition
US11767337B2 (en) 2020-02-18 2023-09-26 Gilead Sciences, Inc. Antiviral compounds
US12030903B2 (en) 2020-02-18 2024-07-09 Gilead Sciences, Inc. Antiviral compounds
US12054507B2 (en) 2020-02-18 2024-08-06 Gilead Sciences, Inc. Antiviral compounds
US11697666B2 (en) 2021-04-16 2023-07-11 Gilead Sciences, Inc. Methods of preparing carbanucleosides using amides

Also Published As

Publication number Publication date
ZA200506886B (en) 2006-05-31
AU2004222079B2 (en) 2008-01-31
KR101273309B1 (en) 2013-06-11
KR20050118196A (en) 2005-12-15
CA2519854A1 (en) 2004-09-30
US7229943B2 (en) 2007-06-12
BRPI0408549B1 (en) 2020-01-21
BRPI0408549A (en) 2006-03-07
AR043667A1 (en) 2005-08-03
CA2519854C (en) 2011-11-22
GB0306430D0 (en) 2003-04-23
EP1603957A1 (en) 2005-12-14
RU2343162C2 (en) 2009-01-10
US20060094588A1 (en) 2006-05-04
TW200427511A (en) 2004-12-16
JP2006520834A (en) 2006-09-14
CN1761688A (en) 2006-04-19
AU2004222079A1 (en) 2004-09-30
RU2005132270A (en) 2006-08-10
CN100491417C (en) 2009-05-27
MXPA05009958A (en) 2006-03-09
TWI359697B (en) 2012-03-11
EP1603957B1 (en) 2015-10-28
JP5401011B2 (en) 2014-01-29

Similar Documents

Publication Publication Date Title
EP1603957B1 (en) Polymerisation and oligomerisation catalysts
US7842638B2 (en) Polymerisation catalyst
EP1776396B1 (en) Polymerisation and oligomerisation catalysts
EP1789459B1 (en) Polyolefins
WO2005111099A1 (en) Ethylene copolymers
US7358209B2 (en) Polymerisation catalysts
CA2412990C (en) Olefin trimerisation using a catalyst comprising a source of chromium, molybdenum or tungsten and a ligand containing at least one phosphorous, arsenic or antimony atom bound to at least one (hetero)hydrocarbyl group
WO1999019335A1 (en) Novel polymerisation catalysts
CA2617436A1 (en) Diene polymerisation catalysts comprising two or more transition metals
WO2006048634A1 (en) Polymerisation catalysts
JP5550808B2 (en) Diene polymerization
US20040087436A1 (en) Novel polymerisation catalysts
WO2006030192A1 (en) Polyolefins
EP1767549A1 (en) Polymerisation catalysts
WO2006030199A1 (en) Polymerisation catalysts

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004721578

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2004222079

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2005/06886

Country of ref document: ZA

Ref document number: 3808/DELNP/2005

Country of ref document: IN

Ref document number: 200506886

Country of ref document: ZA

ENP Entry into the national phase

Ref document number: 2004222079

Country of ref document: AU

Date of ref document: 20040318

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004222079

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2006094588

Country of ref document: US

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 10549314

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2519854

Country of ref document: CA

Ref document number: PA/a/2005/009958

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2006505990

Country of ref document: JP

Ref document number: 1020057017626

Country of ref document: KR

Ref document number: 20048075676

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2005132270

Country of ref document: RU

WWP Wipo information: published in national office

Ref document number: 2004721578

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020057017626

Country of ref document: KR

ENP Entry into the national phase

Ref document number: PI0408549

Country of ref document: BR

WWP Wipo information: published in national office

Ref document number: 10549314

Country of ref document: US